data_4a4f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4a4f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.9 m95 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.563 ' SG ' HD23 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.563 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' HB3' HD11 ' A' ' 94' ' ' ILE . 99.5 m95 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.505 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.418 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.409 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.2 m-20 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.505 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 N--CA 1.433 -1.303 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.469 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo . . . . . 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 97.9 m95 . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 120.75 0.31 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.51 ' SG ' HD23 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.51 HD23 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.502 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.502 HD23 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.473 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD23 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.496 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.45 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.6 m95 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.424 ' SG ' HD23 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.415 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.424 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 89.0 m95 . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.481 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.466 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo . . . . . 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.511 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.511 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 . . . . . 0 C--O 1.243 0.752 0 CA-C-O 119.875 -0.107 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.445 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 93.6 m95 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.475 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.5 m95 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.449 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.425 HD23 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.468 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.491 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.434 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.48 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.434 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.405 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -69.89 -57.51 4.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -108.93 138.78 44.73 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -97.38 114.31 64.63 Favored Pre-proline 0 N--CA 1.416 -2.14 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.89 147.48 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.129 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -77.06 -26.25 53.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -84.8 121.1 27.23 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.544 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 m -104.68 109.76 21.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.974 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -124.02 152.28 42.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.563 ' SG ' HD23 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.427 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.563 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.47 145.53 42.7 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 79' ' ' CYS . 23.1 m -94.05 177.72 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.984 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.08 146.22 32.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 62.96 26.35 15.48 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.285 0.634 . . . . 0.0 112.063 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.321 179.136 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.051 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -68.9 -50.22 51.43 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 m -87.53 96.87 10.56 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -74.33 120.49 81.69 Favored Pre-proline 0 C--O 1.243 0.729 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.508 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.15 152.73 18.58 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.2 1.933 . . . . 0.0 111.502 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.4 m -74.02 -30.32 62.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.427 0.632 . . . . 0.0 110.312 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.463 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.5 m170 -80.23 131.91 35.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.208 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 p -112.28 113.97 26.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.168 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.463 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.5 m95 -123.98 152.23 42.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.006 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.505 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.418 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.409 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.558 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.2 m-20 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.505 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.31 147.95 88.06 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.0 m -77.43 148.03 6.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.84 164.28 14.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.78 116.59 10.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.424 0.631 . . . . 0.0 112.148 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.185 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.375 0.131 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -101.18 -54.17 2.85 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.5 m -105.73 147.81 28.15 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -120.31 136.54 25.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 O-C-N 122.318 -0.239 . . . . 0.0 111.096 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -58.19 149.93 69.28 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.417 2.745 . . . . 0.0 113.24 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 m -96.86 -27.17 14.81 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -114.41 137.1 52.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -98.46 106.7 19.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.707 0.765 . . . . 0.0 110.708 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -117.85 151.51 37.21 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.013 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.469 ' SG ' HD23 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.469 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.426 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -76.58 142.21 23.02 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.8 m -67.2 141.26 18.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.604 0.716 . . . . 0.0 112.713 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -101.6 89.41 3.7 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 122.152 0.977 . . . . 0.0 108.831 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -93.32 -8.52 41.77 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.094 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.734 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 176.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -81.22 -38.94 26.15 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -76.58 105.55 7.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.284 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -76.89 126.43 85.69 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.932 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.35 134.81 34.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.754 2.303 . . . . 0.0 113.259 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -73.99 -31.93 63.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.238 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -106.96 154.58 20.87 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.888 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.4 m -118.77 113.13 20.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -112.44 152.68 28.43 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.658 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD23 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.46 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -73.31 149.01 44.54 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.85 154.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.764 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -86.36 170.33 12.13 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.964 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.92 121.94 17.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.811 0 CA-C-O 118.215 -1.325 . . . . 0.0 110.279 178.371 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -83.95 -30.35 26.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.676 0.751 . . . . 0.0 109.618 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -148.49 120.22 8.08 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.6 131.09 68.99 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.8 155.61 62.2 Favored 'Trans proline' 0 C--N 1.331 -0.359 0 C-N-CA 122.616 2.211 . . . . 0.0 111.516 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 -11.15 59.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.796 0.332 . . . . 0.0 111.127 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.523 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 79.1 m-70 -65.3 121.19 14.24 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 m -102.34 109.16 20.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.523 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 97.9 m95 -118.88 151.33 38.31 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.535 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.444 HD23 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.41 145.65 34.18 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.34 152.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.987 0.422 . . . . 0.0 111.591 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.55 158.11 19.57 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.145 0.498 . . . . 0.0 111.765 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -146.67 102.4 3.55 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.773 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.828 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -73.22 -55.54 6.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -95.12 109.53 21.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.642 0.258 . . . . 0.0 111.614 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -73.06 119.79 77.49 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.457 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.67 134.72 59.44 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.669 2.246 . . . . 0.0 112.128 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.2 t -77.35 -27.33 52.63 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.4 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 91.5 m-70 -133.72 134.28 42.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -83.0 107.83 15.88 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.4 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 97.4 m95 -104.52 151.63 23.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.483 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.483 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.83 150.34 61.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -87.6 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.84 152.07 21.45 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.44 156.9 16.88 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.751 0.31 . . . . 0.0 110.544 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.671 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 178.286 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 m -152.6 -67.98 0.16 Allowed 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.85 -0.531 . . . . 0.0 110.993 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -98.46 107.75 20.28 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -80.01 115.3 53.29 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.22 143.23 17.48 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.632 2.221 . . . . 0.0 113.204 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -77.4 -27.92 52.59 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 109.577 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -83.01 125.88 31.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.524 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -101.42 124.74 47.57 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -125.66 151.32 46.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.51 ' SG ' HD23 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.402 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.51 HD23 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.65 141.2 49.33 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.99 152.06 8.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.11 0.481 . . . . 0.0 112.179 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -104.06 151.13 23.62 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.441 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.78 37.37 4.43 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.167 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 119.145 -0.809 . . . . 0.0 111.206 -178.449 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -66.03 -49.22 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 109.389 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.5 m -105.86 125.46 51.02 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -68.07 149.07 98.3 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.53 157.89 17.5 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.523 2.815 . . . . 0.0 112.575 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.3 m -72.38 -15.29 61.85 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.685 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -136.83 162.22 33.84 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.371 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -112.93 108.05 16.85 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.887 0.875 . . . . 0.0 109.289 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -123.23 152.53 41.2 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.502 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.502 HD23 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.42 129.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.699 0.762 . . . . 0.0 112.368 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -97.64 177.16 5.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -95.62 -6.37 40.32 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.187 0.518 . . . . 0.0 110.489 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.833 0 CA-C-O 118.146 -1.364 . . . . 0.0 109.867 -177.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.4 m -76.13 -31.53 58.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 109.855 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -108.88 109.76 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -75.49 116.67 57.03 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.3 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 58.8 Cg_endo -74.88 135.32 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.138 1.892 . . . . 0.0 112.028 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -91.95 -25.23 18.97 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.399 0.619 . . . . 0.0 109.63 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -82.35 156.94 23.96 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.6 t -118.67 112.38 19.73 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -116.76 150.65 37.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.758 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HB3' HG13 ' A' ' 125' ' ' VAL . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 69' ' ' PRO . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.46 152.91 49.66 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 78' ' ' LYS . 22.4 m -87.55 -178.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 120.648 0.261 . . . . 0.0 110.594 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -76.71 82.63 3.33 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.01 0.91 . . . . 0.0 109.509 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.94 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.074 -1.875 . . . . 0.0 106.721 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.005 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.83 179.127 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m 69.16 -77.1 0.05 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.286 1.034 . . . . 0.0 111.72 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -176.06 136.91 0.3 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -99.14 132.96 22.52 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.93 152.53 57.37 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 122.492 2.128 . . . . 0.0 110.735 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -85.18 3.59 38.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.021 0.439 . . . . 0.0 110.563 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.477 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 40.2 m170 -78.54 122.6 26.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.7 m -99.61 116.64 32.18 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.477 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.3 m95 -124.11 151.06 44.34 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.186 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD23 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.71 146.02 29.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 m -73.96 159.98 5.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.73 147.53 41.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.41 109.27 14.66 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.397 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -71.52 -41.01 69.74 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -108.37 134.41 51.22 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -96.88 151.84 38.04 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.268 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -49.72 133.98 33.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.447 2.765 . . . . 0.0 112.902 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -80.33 -31.85 37.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.954 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.453 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 70.5 m-70 -136.65 162.49 32.99 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.4 m -95.44 109.55 21.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.453 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 96.4 m95 -121.04 144.77 48.36 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.496 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.506 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.45 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.98 146.31 29.13 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.2 m -76.86 137.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.38 137.34 36.51 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -107.33 98.16 7.82 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-O 121.575 0.702 . . . . 0.0 110.442 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.236 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -74.2 -51.01 16.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.462 ' HB ' HD23 ' A' ' 120' ' ' LEU . 6.3 m -68.45 128.85 38.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.648 -176.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -83.62 126.62 70.65 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.29 134.13 26.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.77 1.647 . . . . 0.0 112.518 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.98 -6.88 16.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -83.8 127.53 33.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.166 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 m -102.59 114.19 28.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -116.78 152.06 35.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.424 ' SG ' HD23 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.666 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.444 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.462 HD23 ' HB ' ' A' ' 67' ' ' THR . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.424 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -68.89 149.84 72.78 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.44 119.89 13.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.861 0.839 . . . . 0.0 112.411 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.666 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 12.3 pt-20 -98.01 22.95 8.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.874 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.57 25.44 11.71 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.401 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.109 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 178.892 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m -115.98 7.43 14.36 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.793 0.33 . . . . 0.0 111.607 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 p -98.35 166.15 11.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.636 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -74.26 126.66 88.83 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.15 153.31 56.99 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.431 2.087 . . . . 0.0 112.353 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -99.38 -13.84 19.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -97.2 120.91 38.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.482 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 m -96.73 117.53 31.23 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -118.36 145.29 45.25 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.237 -176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.466 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.481 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.466 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 149.68 89.11 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.03 120.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.757 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -100.6 128.79 46.54 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.73 0.776 . . . . 0.0 110.969 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -95.73 -21.67 18.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.53 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.402 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 178.857 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -78.59 -50.99 10.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.7 m -92.03 106.71 18.67 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.669 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.65 146.04 36.41 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.9 146.62 97.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.794 2.33 . . . . 0.0 112.15 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -76.59 -13.29 60.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.525 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 55.0 m170 -58.55 120.13 8.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -104.82 116.35 31.85 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.525 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.1 m95 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.425 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.511 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.469 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.511 HD23 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.48 148.6 42.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.58 154.86 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.53 143.69 29.16 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -80.6 85.54 5.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.232 0.539 . . . . 0.0 110.491 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.7 m 69.84 15.62 7.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.477 1.111 . . . . 0.0 112.469 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -168.78 172.15 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.07 137.74 23.57 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 123.334 0.396 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.26 151.01 70.61 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.345 2.03 . . . . 0.0 110.35 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -73.06 -33.28 65.57 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.216 0.532 . . . . 0.0 109.793 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -142.08 153.09 43.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -87.64 110.62 20.53 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.352 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -124.22 150.91 44.72 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.82 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HB3' HG13 ' A' ' 125' ' ' VAL . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.433 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.445 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 153.98 55.39 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 78' ' ' LYS . 30.4 m -93.17 173.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 120.966 0.413 . . . . 0.0 111.805 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.99 139.78 46.05 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -127.07 132.51 50.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.041 0.448 . . . . 0.0 111.605 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.833 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.6 m -70.64 -49.26 49.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.703 0.287 . . . . 0.0 111.224 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -111.32 143.33 42.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -87.83 123.61 68.78 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.36 135.34 69.65 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.685 2.257 . . . . 0.0 111.637 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -76.35 -10.39 59.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.43 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 67.5 m80 -104.68 122.7 46.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -96.48 114.55 26.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.241 0.543 . . . . 0.0 109.911 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.43 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 93.6 m95 -120.68 151.6 39.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.559 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.475 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.536 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.475 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.0 146.5 58.86 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.68 129.37 33.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.523 0.677 . . . . 0.0 112.19 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 10.0 pt-20 -97.77 144.94 26.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.403 176.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 14.86 4.11 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.82 0.819 . . . . 0.0 109.671 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.223 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.715 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.036 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 m -74.62 -43.57 54.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 120.938 0.399 . . . . 0.0 109.956 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 p -134.24 144.05 48.18 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -89.3 125.38 62.02 Favored Pre-proline 0 N--CA 1.416 -2.132 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.47 157.7 60.52 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.237 2.625 . . . . 0.0 112.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.7 m -74.79 -29.99 61.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -103.79 147.27 27.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 m -98.84 106.43 18.7 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -92.04 150.96 20.69 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.585 -174.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.425 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.441 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.449 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.425 HD23 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.74 151.46 36.33 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.3 138.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.3 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -103.83 166.6 10.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.569 0.7 . . . . 0.0 110.495 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.14 8.09 5.54 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.187 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.617 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -81.32 -24.51 37.12 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.489 -0.757 . . . . 0.0 112.009 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -94.21 108.69 20.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.478 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.0 104.12 26.84 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.77 144.56 78.07 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.66 2.24 . . . . 0.0 112.88 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.434 HG21 ' CD2' ' A' ' 71' ' ' HIS . 8.8 t -99.21 -11.25 21.5 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.745 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.434 ' CD2' HG21 ' A' ' 70' ' ' THR . 97.6 m-70 -120.64 132.78 55.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.184 -0.323 . . . . 0.0 110.412 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.8 t -97.33 114.72 26.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -122.84 152.12 41.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.681 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.53 ' SG ' HD23 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.468 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.402 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.491 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -71.34 147.26 52.54 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -84.44 126.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.04 145.73 50.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.45 -10.47 0.93 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.284 1.034 . . . . 0.0 112.414 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.081 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -178.496 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -79.3 -30.89 43.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.534 0.683 . . . . 0.0 109.37 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -103.38 131.42 50.47 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.714 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -105.25 128.25 26.99 Favored Pre-proline 0 N--CA 1.416 -2.128 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.1 145.39 96.5 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.476 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.8 m -73.77 -30.89 63.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.317 0.579 . . . . 0.0 109.994 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.4 m170 -83.83 122.68 29.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.59 0.709 . . . . 0.0 111.165 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -97.71 109.55 22.28 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.452 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 98.3 m95 -119.25 152.79 36.06 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.247 0.619 . . . . 0.0 111.738 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.434 ' SG ' HD23 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.48 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.533 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.434 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.97 139.77 24.74 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG13 ' SD ' ' A' ' 80' ' ' MET . 27.8 m -75.26 156.73 6.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.49 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.5 141.87 28.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.77 138.99 31.87 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.268 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.803 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m 68.28 -66.03 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.383 1.473 . . . . 0.0 113.379 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -78.77 105.34 10.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -95.08 118.97 66.45 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.92 150.24 43.48 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.789 2.326 . . . . 0.0 111.924 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -93.55 0.3 56.58 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.298 0.57 . . . . 0.0 110.668 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.0 128.83 56.51 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.7 m -91.53 126.58 36.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -121.33 151.77 39.72 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.729 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.405 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.04 149.24 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.39 143.99 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.491 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.36 150.21 26.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.633 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.05 0.37 51.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.519 0.676 . . . . 0.0 110.683 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.116 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 179.402 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.9 m95 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.58 ' SG ' HD22 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.58 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.5 m95 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.2 m-20 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.525 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.1 m95 . . . . . 0 N--CA 1.433 -1.303 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.477 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 73' ' ' TRP . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.44 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.6 m95 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 73' ' ' TRP . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo . . . . . 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 97.9 m95 . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.46 HD22 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 120.75 0.31 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.2 m95 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.529 ' SG ' HD22 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 73' ' ' TRP . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.513 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.487 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 94' ' ' ILE . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 77' ' ' ASP . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.6 m95 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.436 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 94' ' ' ILE . 89.0 m95 . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 73' ' ' TRP . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo . . . . . 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.524 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 . . . . . 0 C--O 1.243 0.752 0 CA-C-O 119.875 -0.107 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' HB3' HD13 ' A' ' 94' ' ' ILE . 93.6 m95 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.492 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.5 m95 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.8 m95 . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.563 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 73' ' ' TRP . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 107' ' ' THR . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' HD13 ' A' ' 94' ' ' ILE . 94.8 m95 . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 73' ' ' TRP . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 106' ' ' ILE . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -69.89 -57.51 4.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -108.93 138.78 44.73 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -97.38 114.31 64.63 Favored Pre-proline 0 N--CA 1.416 -2.14 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.89 147.48 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.129 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -77.06 -26.25 53.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -84.8 121.1 27.23 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.544 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 m -104.68 109.76 21.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.974 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.9 m95 -124.02 152.28 42.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.58 ' SG ' HD22 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.58 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.47 145.53 42.7 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 79' ' ' CYS . 23.1 m -94.05 177.72 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.984 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.08 146.22 32.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 62.96 26.35 15.48 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.285 0.634 . . . . 0.0 112.063 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.321 179.136 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.051 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -68.9 -50.22 51.43 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 m -87.53 96.87 10.56 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -74.33 120.49 81.69 Favored Pre-proline 0 C--O 1.243 0.729 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.508 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.15 152.73 18.58 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.2 1.933 . . . . 0.0 111.502 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.4 m -74.02 -30.32 62.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.427 0.632 . . . . 0.0 110.312 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.5 m170 -80.23 131.91 35.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.208 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 p -112.28 113.97 26.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.168 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.481 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.5 m95 -123.98 152.23 42.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.006 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HB3' HG11 ' A' ' 125' ' ' VAL . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 107' ' ' THR . 10.0 m120 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.525 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.31 147.95 88.06 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 78' ' ' LYS . 17.0 m -77.43 148.03 6.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.84 164.28 14.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.78 116.59 10.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.424 0.631 . . . . 0.0 112.148 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.185 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.375 0.131 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -101.18 -54.17 2.85 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.5 m -105.73 147.81 28.15 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 13.1 pt20 -120.31 136.54 25.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 O-C-N 122.318 -0.239 . . . . 0.0 111.096 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 54.9 Cg_exo -58.19 149.93 69.28 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.417 2.745 . . . . 0.0 113.24 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 m -96.86 -27.17 14.81 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -114.41 137.1 52.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -98.46 106.7 19.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.707 0.765 . . . . 0.0 110.708 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.1 m95 -117.85 151.51 37.21 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.013 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HB3' HG11 ' A' ' 125' ' ' VAL . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.477 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 73' ' ' TRP . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -76.58 142.21 23.02 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 78' ' ' LYS . 30.8 m -67.2 141.26 18.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.604 0.716 . . . . 0.0 112.713 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -101.6 89.41 3.7 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 122.152 0.977 . . . . 0.0 108.831 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -93.32 -8.52 41.77 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.094 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.734 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 176.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -81.22 -38.94 26.15 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -76.58 105.55 7.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.284 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -76.89 126.43 85.69 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.932 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.35 134.81 34.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.754 2.303 . . . . 0.0 113.259 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -73.99 -31.93 63.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.238 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -106.96 154.58 20.87 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.888 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.4 m -118.77 113.13 20.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.44 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.6 m95 -112.44 152.68 28.43 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.658 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 73' ' ' TRP . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -73.31 149.01 44.54 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.85 154.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.764 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -86.36 170.33 12.13 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.964 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.92 121.94 17.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.811 0 CA-C-O 118.215 -1.325 . . . . 0.0 110.279 178.371 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -83.95 -30.35 26.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.676 0.751 . . . . 0.0 109.618 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -148.49 120.22 8.08 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.6 131.09 68.99 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.8 155.61 62.2 Favored 'Trans proline' 0 C--N 1.331 -0.359 0 C-N-CA 122.616 2.211 . . . . 0.0 111.516 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 -11.15 59.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.796 0.332 . . . . 0.0 111.127 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.533 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 79.1 m-70 -65.3 121.19 14.24 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 m -102.34 109.16 20.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.533 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 97.9 m95 -118.88 151.33 38.31 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.535 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.46 HD22 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.41 145.65 34.18 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.34 152.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.987 0.422 . . . . 0.0 111.591 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.55 158.11 19.57 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.145 0.498 . . . . 0.0 111.765 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -146.67 102.4 3.55 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.773 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.828 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -73.22 -55.54 6.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -95.12 109.53 21.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.642 0.258 . . . . 0.0 111.614 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -73.06 119.79 77.49 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.457 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.67 134.72 59.44 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.669 2.246 . . . . 0.0 112.128 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.2 t -77.35 -27.33 52.63 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 76.5 m80 -133.72 134.28 42.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -83.0 107.83 15.88 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 97.4 m95 -104.52 151.63 23.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.83 150.34 61.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -87.6 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -89.84 152.07 21.45 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -92.44 156.9 16.88 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.751 0.31 . . . . 0.0 110.544 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.671 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 178.286 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 m -152.6 -67.98 0.16 Allowed 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.85 -0.531 . . . . 0.0 110.993 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -98.46 107.75 20.28 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -80.01 115.3 53.29 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.22 143.23 17.48 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.632 2.221 . . . . 0.0 113.204 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -77.4 -27.92 52.59 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 109.577 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -83.01 125.88 31.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.524 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -101.42 124.74 47.57 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.2 m95 -125.66 151.32 46.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.529 ' SG ' HD22 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.445 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 73' ' ' TRP . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.65 141.2 49.33 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.445 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 26.9 m -70.99 152.06 8.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.11 0.481 . . . . 0.0 112.179 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -104.06 151.13 23.62 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.441 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.78 37.37 4.43 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.167 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 119.145 -0.809 . . . . 0.0 111.206 -178.449 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -66.03 -49.22 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 109.389 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.5 m -105.86 125.46 51.02 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -68.07 149.07 98.3 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.53 157.89 17.5 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.523 2.815 . . . . 0.0 112.575 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.3 m -72.38 -15.29 61.85 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.685 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -136.83 162.22 33.84 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.371 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -112.93 108.05 16.85 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.887 0.875 . . . . 0.0 109.289 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -123.23 152.53 41.2 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.42 129.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.699 0.762 . . . . 0.0 112.368 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -97.64 177.16 5.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -95.62 -6.37 40.32 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.187 0.518 . . . . 0.0 110.489 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.833 0 CA-C-O 118.146 -1.364 . . . . 0.0 109.867 -177.897 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.4 m -76.13 -31.53 58.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 109.855 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -108.88 109.76 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -75.49 116.67 57.03 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.3 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 58.8 Cg_endo -74.88 135.32 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.138 1.892 . . . . 0.0 112.028 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -91.95 -25.23 18.97 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.399 0.619 . . . . 0.0 109.63 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -82.35 156.94 23.96 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.6 t -118.67 112.38 19.73 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -116.76 150.65 37.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.758 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HB3' HG11 ' A' ' 125' ' ' VAL . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' PRO . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.46 152.91 49.66 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 78' ' ' LYS . 22.4 m -87.55 -178.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 120.648 0.261 . . . . 0.0 110.594 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -76.71 82.63 3.33 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.01 0.91 . . . . 0.0 109.509 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.94 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.074 -1.875 . . . . 0.0 106.721 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.005 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.83 179.127 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m 69.16 -77.1 0.05 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.286 1.034 . . . . 0.0 111.72 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -176.06 136.91 0.3 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -99.14 132.96 22.52 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.93 152.53 57.37 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 122.492 2.128 . . . . 0.0 110.735 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -85.18 3.59 38.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.021 0.439 . . . . 0.0 110.563 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 40.2 m170 -78.54 122.6 26.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.7 m -99.61 116.64 32.18 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.491 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.3 m95 -124.11 151.06 44.34 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.186 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 94' ' ' ILE . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.467 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 77' ' ' ASP . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.71 146.02 29.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 m -73.96 159.98 5.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.73 147.53 41.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.41 109.27 14.66 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.397 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -71.52 -41.01 69.74 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -108.37 134.41 51.22 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -96.88 151.84 38.04 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.268 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -49.72 133.98 33.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.447 2.765 . . . . 0.0 112.902 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -80.33 -31.85 37.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.954 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.476 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 70.5 m-70 -136.65 162.49 32.99 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.4 m -95.44 109.55 21.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.476 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 96.4 m95 -121.04 144.77 48.36 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.98 146.31 29.13 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.2 m -76.86 137.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.38 137.34 36.51 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -107.33 98.16 7.82 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-O 121.575 0.702 . . . . 0.0 110.442 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.236 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -74.2 -51.01 16.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 120' ' ' LEU . 6.3 m -68.45 128.85 38.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.648 -176.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -83.62 126.62 70.65 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.29 134.13 26.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.77 1.647 . . . . 0.0 112.518 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.98 -6.88 16.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -83.8 127.53 33.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.166 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 m -102.59 114.19 28.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.6 m95 -116.78 152.06 35.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -174.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 67' ' ' THR . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.436 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -68.89 149.84 72.78 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.44 119.89 13.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.861 0.839 . . . . 0.0 112.411 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.677 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 12.3 pt-20 -98.01 22.95 8.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.874 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.57 25.44 11.71 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.401 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.109 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 178.892 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m -115.98 7.43 14.36 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.793 0.33 . . . . 0.0 111.607 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 p -98.35 166.15 11.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.636 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -74.26 126.66 88.83 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.15 153.31 56.99 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.431 2.087 . . . . 0.0 112.353 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -99.38 -13.84 19.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -97.2 120.91 38.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.482 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 m -96.73 117.53 31.23 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 94' ' ' ILE . 89.0 m95 -118.36 145.29 45.25 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.237 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 73' ' ' TRP . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 149.68 89.11 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.03 120.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.757 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -100.6 128.79 46.54 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.73 0.776 . . . . 0.0 110.969 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -95.73 -21.67 18.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.53 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.402 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 178.857 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -78.59 -50.99 10.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.7 m -92.03 106.71 18.67 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.669 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.65 146.04 36.41 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.9 146.62 97.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.794 2.33 . . . . 0.0 112.15 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -76.59 -13.29 60.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 55.0 m170 -58.55 120.13 8.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -104.82 116.35 31.85 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.1 m95 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.425 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.524 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.48 148.6 42.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.58 154.86 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.53 143.69 29.16 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -80.6 85.54 5.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.232 0.539 . . . . 0.0 110.491 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.472 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.7 m 69.84 15.62 7.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.477 1.111 . . . . 0.0 112.469 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -168.78 172.15 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.07 137.74 23.57 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 123.334 0.396 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.26 151.01 70.61 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.345 2.03 . . . . 0.0 110.35 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -73.06 -33.28 65.57 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.216 0.532 . . . . 0.0 109.793 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -142.08 153.09 43.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -87.64 110.62 20.53 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.352 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -124.22 150.91 44.72 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.82 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB3' HG11 ' A' ' 125' ' ' VAL . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 153.98 55.39 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 78' ' ' LYS . 30.4 m -93.17 173.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 120.966 0.413 . . . . 0.0 111.805 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.99 139.78 46.05 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -127.07 132.51 50.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.041 0.448 . . . . 0.0 111.605 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.833 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.822 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.6 m -70.64 -49.26 49.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.703 0.287 . . . . 0.0 111.224 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -111.32 143.33 42.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -87.83 123.61 68.78 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.36 135.34 69.65 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.685 2.257 . . . . 0.0 111.637 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -76.35 -10.39 59.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.443 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 67.5 m80 -104.68 122.7 46.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -96.48 114.55 26.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.241 0.543 . . . . 0.0 109.911 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 93.6 m95 -120.68 151.6 39.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.559 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.548 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.492 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.0 146.5 58.86 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.68 129.37 33.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.523 0.677 . . . . 0.0 112.19 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 10.0 pt-20 -97.77 144.94 26.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.403 176.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 14.86 4.11 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.82 0.819 . . . . 0.0 109.671 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.223 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.715 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.036 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 m -74.62 -43.57 54.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 120.938 0.399 . . . . 0.0 109.956 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 p -134.24 144.05 48.18 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.3 125.38 62.02 Favored Pre-proline 0 N--CA 1.416 -2.132 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.47 157.7 60.52 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.237 2.625 . . . . 0.0 112.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.7 m -74.79 -29.99 61.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -103.79 147.27 27.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 m -98.84 106.43 18.7 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.5 m95 -92.04 150.96 20.69 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.585 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.74 151.46 36.33 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.3 138.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.3 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -103.83 166.6 10.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.569 0.7 . . . . 0.0 110.495 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.14 8.09 5.54 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.187 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.617 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -81.32 -24.51 37.12 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.489 -0.757 . . . . 0.0 112.009 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -94.21 108.69 20.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.478 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.0 104.12 26.84 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.77 144.56 78.07 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.66 2.24 . . . . 0.0 112.88 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 t -99.21 -11.25 21.5 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.745 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -120.64 132.78 55.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.184 -0.323 . . . . 0.0 110.412 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.8 t -97.33 114.72 26.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.8 m95 -122.84 152.12 41.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.681 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 125' ' ' VAL . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.563 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 73' ' ' TRP . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -71.34 147.26 52.54 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.417 HG21 ' HE3' ' A' ' 78' ' ' LYS . 27.6 m -84.44 126.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.04 145.73 50.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.45 -10.47 0.93 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.284 1.034 . . . . 0.0 112.414 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.081 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -178.496 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 100' ' ' GLU . . . . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -79.3 -30.89 43.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.534 0.683 . . . . 0.0 109.37 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -103.38 131.42 50.47 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.714 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.3 tt0 -105.25 128.25 26.99 Favored Pre-proline 0 N--CA 1.416 -2.128 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 37.7 Cg_exo -62.1 145.39 96.5 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.476 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.8 m -73.77 -30.89 63.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.317 0.579 . . . . 0.0 109.994 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.4 m170 -83.83 122.68 29.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.59 0.709 . . . . 0.0 111.165 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -97.71 109.55 22.28 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.465 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 98.3 m95 -119.25 152.79 36.06 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.247 0.619 . . . . 0.0 111.738 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 107' ' ' THR . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.97 139.77 24.74 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG12 ' SD ' ' A' ' 80' ' ' MET . 27.8 m -75.26 156.73 6.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.49 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.5 141.87 28.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.77 138.99 31.87 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.268 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.803 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m 68.28 -66.03 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.383 1.473 . . . . 0.0 113.379 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -78.77 105.34 10.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -95.08 118.97 66.45 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.92 150.24 43.48 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.789 2.326 . . . . 0.0 111.924 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -93.55 0.3 56.58 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.298 0.57 . . . . 0.0 110.668 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.0 128.83 56.51 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.7 m -91.53 126.58 36.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' HD13 ' A' ' 94' ' ' ILE . 94.8 m95 -121.33 151.77 39.72 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.729 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HB3' HG11 ' A' ' 125' ' ' VAL . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 73' ' ' TRP . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 106' ' ' ILE . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.04 149.24 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 78' ' ' LYS . 34.5 m -76.39 143.99 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.36 150.21 26.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.633 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.05 0.37 51.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.519 0.676 . . . . 0.0 110.683 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.116 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 179.402 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.9 m95 . . . . . 0 N--CA 1.442 -0.838 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.58 ' SG ' HD22 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.58 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.5 m95 . . . . . 0 CA--C 1.503 -0.863 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.2 m-20 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.525 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo . . . . . 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.422 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.1 m95 . . . . . 0 N--CA 1.433 -1.303 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.477 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 73' ' ' TRP . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.44 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.6 m95 . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 73' ' ' TRP . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo . . . . . 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 94' ' ' ILE . 97.9 m95 . . . . . 0 N--CA 1.431 -1.404 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.46 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.46 HD22 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.4 m95 . . . . . 0 N--CA 1.432 -1.326 0 CA-C-O 120.75 0.31 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo . . . . . 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.2 m95 . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.529 ' SG ' HD22 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 73' ' ' TRP . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 . . . . . 0 CA--C 1.513 -0.458 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.513 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo . . . . . 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.487 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.3 m95 . . . . . 0 N--CA 1.435 -1.187 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 94' ' ' ILE . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 77' ' ' ASP . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 . . . . . 0 N--CA 1.434 -1.235 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.6 m95 . . . . . 0 CA--C 1.506 -0.744 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.416 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.436 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo . . . . . 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 94' ' ' ILE . 89.0 m95 . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 111.237 0.088 . . . . 0.0 111.237 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.479 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 73' ' ' TRP . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo . . . . . 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.524 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 . . . . . 0 C--O 1.243 0.752 0 CA-C-O 119.875 -0.107 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' HB3' HD13 ' A' ' 94' ' ' ILE . 93.6 m95 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.492 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.5 m95 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.8 m95 . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.563 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 73' ' ' TRP . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.3 m95 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 107' ' ' THR . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo . . . . . 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' HD13 ' A' ' 94' ' ' ILE . 94.8 m95 . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 73' ' ' TRP . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 106' ' ' ILE . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -69.89 -57.51 4.96 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.1 t -108.93 138.78 44.73 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -97.38 114.31 64.63 Favored Pre-proline 0 N--CA 1.416 -2.14 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.89 147.48 11.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.129 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.5 t -77.06 -26.25 53.33 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -84.8 121.1 27.23 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.544 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.1 m -104.68 109.76 21.82 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.974 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.421 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.9 m95 -124.02 152.28 42.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' HG3' ' OD1' ' A' ' 77' ' ' ASP . 7.8 ptmm? -132.55 160.59 36.12 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.19 0.519 . . . . 0.0 111.624 175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.18 133.63 28.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.936 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 101.94 -8.69 56.15 Favored Glycine 0 CA--C 1.497 -1.037 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.125 176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.411 ' OD1' ' HG3' ' A' ' 74' ' ' LYS . 0.9 OUTLIER -96.81 144.05 27.15 Favored 'General case' 0 CA--C 1.463 -2.395 0 C-N-CA 123.078 0.551 . . . . 0.0 110.094 -177.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -101.66 147.88 25.91 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-O 122.218 1.009 . . . . 0.0 111.839 175.067 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.58 ' SG ' HD22 ' A' ' 122' ' ' LEU . 12.0 p -141.78 178.65 7.35 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.278 -173.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 35.1 mtp -108.7 129.45 55.35 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.63 151.12 37.84 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.8 t -87.35 114.07 25.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -68.2 117.02 9.47 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.6 t -57.91 -23.49 53.56 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 123.896 0.748 . . . . 0.0 111.578 -176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -82.6 -35.91 26.64 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 24.4 t70 -109.57 -19.04 13.35 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 121.547 0.689 . . . . 0.0 112.207 -175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.3 12.79 83.96 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.429 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.39 168.46 9.83 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.472 -0.428 . . . . 0.0 110.587 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.1 p -99.6 134.3 42.69 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.243 0.544 . . . . 0.0 111.28 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.39 157.74 45.62 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.67 124.03 25.19 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-O 121.652 0.739 . . . . 0.0 110.272 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 138.43 37.79 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.047 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 36.9 tt0 -100.33 132.67 45.58 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.131 -176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.3 mt -72.83 121.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -94.31 -40.92 9.71 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.818 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -157.56 150.02 22.77 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.4 mt -123.78 133.72 68.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.075 0.464 . . . . 0.0 110.11 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -107.79 93.79 4.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -66.49 -17.74 64.97 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 123.257 0.623 . . . . 0.0 112.383 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -64.79 -43.54 92.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.241 0.544 . . . . 0.0 109.862 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -105.91 -13.69 15.43 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.188 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.412 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.54 29.57 55.24 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -175.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.2 p -113.7 155.89 24.75 Favored 'General case' 0 N--CA 1.437 -1.076 0 O-C-N 122.269 -0.547 . . . . 0.0 110.726 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.22 145.41 50.53 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.099 0.476 . . . . 0.0 110.545 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.03 122.08 35.02 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.57 148.27 30.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.99 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.6 m -114.25 125.08 53.51 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.98 118.65 15.11 Favored 'General case' 0 CA--C 1.5 -0.981 0 C-N-CA 122.618 0.367 . . . . 0.0 110.933 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.19 131.08 45.34 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.432 1.083 . . . . 0.0 110.902 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.27 -55.2 2.11 Favored Glycine 0 C--N 1.307 -1.034 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.946 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -72.43 -45.59 58.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.876 0.37 . . . . 0.0 110.272 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.38 47.58 4.86 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.969 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -121.17 172.98 7.59 Favored 'General case' 0 CA--C 1.483 -1.607 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -147.5 138.07 23.32 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 123.09 0.244 . . . . 0.0 110.417 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 106' ' ' ILE . 5.7 pt-20 -142.98 157.57 44.43 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.4 t -99.53 110.71 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.8 t -126.61 141.54 40.53 Favored Pre-proline 0 C--N 1.277 -2.581 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.0 Cg_endo -60.25 151.23 75.1 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.348 2.032 . . . . 0.0 112.129 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 85.3 mt -59.7 -26.77 65.86 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 123.394 0.678 . . . . 0.0 111.054 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -66.71 -26.01 66.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.604 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -90.84 -1.4 57.85 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.58 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -93.64 131.18 39.19 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 59.1 mttm -113.89 154.66 45.89 Favored Pre-proline 0 C--N 1.295 -1.765 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.707 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.47 145.53 42.7 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.527 2.152 . . . . 0.0 110.926 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 79' ' ' CYS . 23.1 m -94.05 177.72 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.984 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.08 146.22 32.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 62.96 26.35 15.48 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.285 0.634 . . . . 0.0 112.063 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.321 179.136 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.051 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.7 m -68.9 -50.22 51.43 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 m -87.53 96.87 10.56 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -74.33 120.49 81.69 Favored Pre-proline 0 C--O 1.243 0.729 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.508 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.15 152.73 18.58 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.2 1.933 . . . . 0.0 111.502 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.4 m -74.02 -30.32 62.38 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.427 0.632 . . . . 0.0 110.312 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.5 m170 -80.23 131.91 35.77 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.208 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 p -112.28 113.97 26.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.168 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.481 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.5 m95 -123.98 152.23 42.76 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.006 -174.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -131.93 161.41 33.14 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 123.423 0.452 . . . . 0.0 110.879 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.54 139.24 21.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.772 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.52 5.83 71.47 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 116.273 -0.422 . . . . 0.0 112.187 176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.86 152.27 22.12 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HB3' HG11 ' A' ' 125' ' ' VAL . 64.1 mmtt -91.51 136.09 33.37 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.4 p -143.02 177.71 8.18 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.442 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.9 mtp -119.79 129.47 54.47 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.04 153.14 35.2 Favored 'General case' 0 C--N 1.281 -2.385 0 O-C-N 123.785 0.678 . . . . 0.0 109.467 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.18 114.13 25.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -68.2 115.53 7.78 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.6 t -60.65 -18.88 56.3 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 123.994 0.808 . . . . 0.0 111.563 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -84.43 -30.57 25.22 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.1 t70 -114.48 -19.15 11.29 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.763 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.26 9.66 86.31 Favored Glycine 0 C--N 1.306 -1.087 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.914 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -114.27 166.16 11.94 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 122.478 -0.425 . . . . 0.0 110.866 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 21.3 p -99.82 134.39 42.79 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.932 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -136.32 158.62 43.99 Favored 'General case' 0 C--N 1.311 -1.095 0 C-N-CA 124.793 1.237 . . . . 0.0 108.22 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -73.74 132.46 42.68 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.475 0.655 . . . . 0.0 110.485 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.58 150.29 38.62 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.194 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -110.05 137.1 48.28 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.7 mt -77.54 123.12 33.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.902 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -96.99 -41.95 8.14 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.159 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -154.66 149.51 26.65 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -175.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.8 mt -122.95 133.14 69.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.03 91.86 4.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.78 -17.35 64.56 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -176.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -69.13 -42.49 75.96 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -100.62 -14.01 18.33 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.978 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.69 34.11 54.26 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -174.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.9 p -113.76 160.79 18.3 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.694 -0.253 . . . . 0.0 110.377 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 145.17 42.42 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.109 0.48 . . . . 0.0 110.772 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.47 120.19 33.45 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.53 146.79 30.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.239 -172.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 55.6 m -113.44 122.87 48.62 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.354 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -70.17 127.49 33.0 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.549 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.03 121.55 12.72 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.492 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.61 -49.2 3.39 Favored Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.923 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -73.78 -39.34 64.22 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.059 0.457 . . . . 0.0 110.702 -176.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.6 21.4 47.8 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 114.835 0.694 . . . . 0.0 114.835 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.2 m-20 -96.22 167.6 11.1 Favored 'General case' 0 CA--C 1.479 -1.761 0 C-N-CA 119.042 -1.063 . . . . 0.0 109.453 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.92 133.51 28.63 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -138.14 157.5 46.2 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -97.98 110.23 25.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -126.22 140.83 38.06 Favored Pre-proline 0 C--N 1.277 -2.579 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -175.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.8 Cg_endo -61.27 147.5 95.43 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.431 2.087 . . . . 0.0 111.616 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.7 mt -56.11 -27.05 52.29 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.657 0.783 . . . . 0.0 111.205 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -62.7 -28.56 70.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.736 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -88.61 -4.66 58.52 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.663 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.525 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -95.2 131.01 41.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.096 0.474 . . . . 0.0 110.619 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.7 mttm -115.28 154.73 47.46 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.88 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.31 147.95 88.06 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 122.764 2.31 . . . . 0.0 109.406 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 78' ' ' LYS . 17.0 m -77.43 148.03 6.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -114.84 164.28 14.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -140.78 116.59 10.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.424 0.631 . . . . 0.0 112.148 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.887 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 178.185 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.375 0.131 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.0 m -101.18 -54.17 2.85 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.5 m -105.73 147.81 28.15 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 13.1 pt20 -120.31 136.54 25.23 Favored Pre-proline 0 C--N 1.311 -1.105 0 O-C-N 122.318 -0.239 . . . . 0.0 111.096 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 54.9 Cg_exo -58.19 149.93 69.28 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.417 2.745 . . . . 0.0 113.24 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.3 m -96.86 -27.17 14.81 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -114.41 137.1 52.25 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.0 m -98.46 106.7 19.01 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 121.707 0.765 . . . . 0.0 110.708 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.422 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.1 m95 -117.85 151.51 37.21 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.013 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -124.95 155.86 38.93 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-O 121.37 0.605 . . . . 0.0 111.386 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.93 135.3 27.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.512 175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.45 23.72 42.43 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.444 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -113.85 158.23 21.3 Favored 'General case' 0 CA--C 1.479 -1.767 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HB3' HG11 ' A' ' 125' ' ' VAL . 30.1 mmtp -96.2 131.07 43.05 Favored 'General case' 0 N--CA 1.398 -3.04 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.477 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.4 p -135.23 176.05 9.02 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 44.8 mtp -115.3 129.71 56.69 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.78 152.83 34.53 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 96.3 t -87.33 113.44 24.75 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.481 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.1 t90 -67.15 118.02 9.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t -56.88 -22.54 37.91 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 124.279 1.032 . . . . 0.0 111.54 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -84.83 -38.51 19.44 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 11.6 t70 -106.04 -19.58 13.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 119.914 -0.715 . . . . 0.0 111.522 -175.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.34 8.49 87.09 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.125 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -115.07 169.55 9.02 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.201 -0.588 . . . . 0.0 111.799 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 9.7 p -98.17 134.49 41.15 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.433 0.635 . . . . 0.0 112.704 -176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -137.84 158.39 44.45 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.682 1.193 . . . . 0.0 108.751 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 125.53 27.97 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 110.753 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.33 148.2 41.01 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.315 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -106.45 136.09 46.82 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 73' ' ' TRP . 66.9 mt -75.53 122.54 29.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.964 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -97.51 -34.55 10.95 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.729 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -158.81 151.92 22.47 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.9 mt -129.25 131.47 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 122.625 0.37 . . . . 0.0 110.596 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -108.35 95.55 5.75 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.77 -22.33 66.57 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.365 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 100' ' ' GLU . 2.8 tp10 -69.29 -35.04 75.6 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.359 0.6 . . . . 0.0 111.414 -176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -104.45 -13.03 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.04 0.448 . . . . 0.0 110.39 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.64 30.88 59.27 Favored Glycine 0 N--CA 1.439 -1.11 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.0 p -114.56 156.94 23.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.618 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.36 48.57 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.002 0.429 . . . . 0.0 110.233 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.36 119.26 32.84 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.4 149.37 30.04 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 -173.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.1 m -120.48 122.92 41.72 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -67.96 126.79 30.59 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 123.612 0.765 . . . . 0.0 111.384 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.1 136.24 37.85 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.0 -51.97 3.2 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -77.78 -49.66 13.9 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-O 120.668 0.27 . . . . 0.0 110.636 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.1 18.89 25.46 Favored Glycine 0 CA--C 1.533 1.205 0 N-CA-C 115.766 1.067 . . . . 0.0 115.766 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.6 m-20 -96.7 166.58 11.59 Favored 'General case' 0 CA--C 1.481 -1.674 0 CA-C-N 118.716 1.258 . . . . 0.0 110.004 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.84 141.36 38.67 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.16 157.06 43.28 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.26 110.76 26.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.1 t -128.5 141.54 41.81 Favored Pre-proline 0 C--N 1.283 -2.32 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -59.53 149.1 84.11 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.529 2.152 . . . . 0.0 111.47 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 77.3 mt -58.18 -26.52 62.86 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.645 0.778 . . . . 0.0 111.388 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.99 -27.04 68.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.45 0.643 . . . . 0.0 109.863 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -86.7 -3.36 59.03 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.924 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.0 mt -98.91 129.47 45.25 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.527 0.68 . . . . 0.0 109.888 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.1 mttm -116.64 162.18 28.22 Favored Pre-proline 0 C--N 1.285 -2.197 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.589 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -76.58 142.21 23.02 Favored 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 121.687 1.591 . . . . 0.0 109.853 173.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' A' ' 78' ' ' LYS . 30.8 m -67.2 141.26 18.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 121.604 0.716 . . . . 0.0 112.713 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -101.6 89.41 3.7 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 122.152 0.977 . . . . 0.0 108.831 177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -93.32 -8.52 41.77 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.094 -175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.734 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 176.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.379 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -81.22 -38.94 26.15 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -76.58 105.55 7.7 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.284 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -76.89 126.43 85.69 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.932 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.35 134.81 34.65 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.754 2.303 . . . . 0.0 113.259 -177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 m -73.99 -31.93 63.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.238 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -106.96 154.58 20.87 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.888 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.4 m -118.77 113.13 20.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.44 ' HB3' HD13 ' A' ' 94' ' ' ILE . 99.6 m95 -112.44 152.68 28.43 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.658 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -125.24 155.34 40.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.099 0.476 . . . . 0.0 110.029 174.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.12 137.47 24.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.925 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.24 14.96 58.15 Favored Glycine 0 C--N 1.315 -0.631 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.958 176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -108.33 163.72 12.94 Favored 'General case' 0 CA--C 1.484 -1.596 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -99.62 130.94 45.89 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 20.9 p -136.28 172.52 12.89 Favored 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.012 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.4 mmm -106.99 128.73 54.61 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.91 150.32 40.08 Favored 'General case' 0 C--N 1.26 -3.318 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.3 t -87.39 114.06 25.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.79 117.19 10.17 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.8 t -59.97 -17.4 37.92 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.512 1.125 . . . . 0.0 111.395 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -85.21 -42.22 14.9 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -106.57 -18.95 13.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.1 12.61 83.87 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.837 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -114.48 167.08 11.03 Favored 'General case' 0 C--N 1.314 -0.945 0 O-C-N 122.657 -0.32 . . . . 0.0 110.536 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.5 p -100.36 134.06 43.87 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.987 0.422 . . . . 0.0 111.49 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -137.03 158.51 44.3 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 109.945 -174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -73.51 125.85 28.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.649 0.738 . . . . 0.0 110.675 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.51 148.59 36.25 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.823 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -105.64 134.81 48.15 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.44 HD13 ' HB3' ' A' ' 73' ' ' TRP . 58.9 mt -74.69 124.79 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.36 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -98.18 -33.61 11.06 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.75 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -158.86 152.55 23.15 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.29 134.86 63.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -111.98 91.01 3.5 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.29 -18.48 65.38 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.77 -1.104 . . . . 0.0 113.127 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -43.91 58.58 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -92.08 -13.68 30.46 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.262 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.78 31.3 58.46 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -174.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.7 p -114.03 166.27 11.78 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 121.019 0.438 . . . . 0.0 111.036 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.402 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.18 145.13 38.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.96 118.73 32.29 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.49 152.26 32.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.996 -172.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.3 m -119.2 123.28 43.95 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -68.29 119.42 12.81 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 123.057 0.543 . . . . 0.0 111.476 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.23 127.47 32.67 Favored 'General case' 0 C--N 1.314 -0.938 0 O-C-N 124.222 0.951 . . . . 0.0 110.225 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.65 -49.58 1.29 Allowed Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.683 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -80.28 -49.66 11.26 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.25 27.84 8.47 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.059 -1.067 . . . . 0.0 115.179 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -106.68 167.47 9.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-N 118.358 1.079 . . . . 0.0 109.477 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.14 136.65 33.73 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.3 159.34 43.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.458 177.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.07 110.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -128.7 140.77 39.46 Favored Pre-proline 0 C--N 1.284 -2.272 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.392 -174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 31.4 Cg_endo -60.79 147.65 94.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.594 2.196 . . . . 0.0 112.612 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 72.2 mt -56.15 -25.5 46.64 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 124.414 1.086 . . . . 0.0 111.473 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -66.53 -33.05 74.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.562 0.696 . . . . 0.0 110.045 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.424 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.5 m-20 -76.86 -26.24 54.03 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.233 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 80' ' ' MET . 85.1 mt -78.11 130.06 35.94 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.756 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.572 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 46.6 mmtm -116.44 157.29 46.04 Favored Pre-proline 0 C--N 1.295 -1.787 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.792 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -73.31 149.01 44.54 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.072 1.848 . . . . 0.0 110.452 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.5 m -81.85 154.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.764 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -86.36 170.33 12.13 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.964 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -68.92 121.94 17.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.243 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.811 0 CA-C-O 118.215 -1.325 . . . . 0.0 110.279 178.371 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.9 m -83.95 -30.35 26.33 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.676 0.751 . . . . 0.0 109.618 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -148.49 120.22 8.08 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -78.6 131.09 68.99 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.8 155.61 62.2 Favored 'Trans proline' 0 C--N 1.331 -0.359 0 C-N-CA 122.616 2.211 . . . . 0.0 111.516 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 -11.15 59.65 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.796 0.332 . . . . 0.0 111.127 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.533 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 79.1 m-70 -65.3 121.19 14.24 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.091 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 m -102.34 109.16 20.74 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.533 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 97.9 m95 -118.88 151.33 38.31 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.535 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -132.49 160.84 35.31 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.14 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 17.99 61.16 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.172 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -99.2 157.39 16.41 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -102.19 128.91 48.5 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.46 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -138.51 177.2 8.06 Favored 'General case' 0 C--N 1.264 -3.126 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.514 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.422 ' HA ' ' O ' ' A' ' 90' ' ' TYR . 55.4 mtp -119.82 129.88 54.64 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 172.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.57 152.67 34.65 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -86.98 113.42 24.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -67.97 116.78 9.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.3 t -59.08 -17.75 28.91 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 124.232 1.013 . . . . 0.0 111.909 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -84.58 -42.56 15.31 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -106.42 -20.0 13.51 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.42 -171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 12.55 81.59 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.826 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -114.69 167.41 10.78 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 117.09 0.445 . . . . 0.0 110.441 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -100.15 134.08 43.6 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.436 0.636 . . . . 0.0 112.195 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 80' ' ' MET . 76.7 m-85 -134.65 157.36 46.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.929 -176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -73.7 126.32 30.06 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.531 0.681 . . . . 0.0 110.639 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.89 152.59 41.33 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.43 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -108.08 136.69 47.35 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 73' ' ' TRP . 62.1 mt -77.12 123.89 34.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.331 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -99.08 -31.09 11.95 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.244 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -158.68 147.47 18.7 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.4 mt -121.37 132.91 69.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -107.17 95.21 5.55 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -66.83 -19.76 65.8 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.923 -177.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -70.31 -42.9 71.38 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -97.59 -13.96 21.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.684 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.76 33.76 54.84 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 21.0 p -114.22 161.08 18.29 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 120.802 0.334 . . . . 0.0 110.761 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.82 145.94 45.07 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.85 120.64 36.47 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.27 151.62 31.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.934 -171.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 87.6 m -116.91 122.99 45.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -67.78 120.97 14.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.865 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.96 124.76 24.86 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.595 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.26 -52.37 0.9 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.423 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -80.23 -47.14 15.08 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.063 0.459 . . . . 0.0 110.016 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.35 13.39 42.0 Favored Glycine 0 N--CA 1.443 -0.852 0 N-CA-C 115.142 0.817 . . . . 0.0 115.142 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.2 m-20 -88.77 169.59 11.5 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 118.663 1.232 . . . . 0.0 109.97 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.43 139.04 33.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -149.48 160.45 43.45 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.453 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -95.68 118.26 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -137.3 140.59 31.25 Favored Pre-proline 0 C--N 1.283 -2.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.7 Cg_endo -60.75 148.11 92.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.503 2.136 . . . . 0.0 112.066 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 81.7 mt -57.13 -26.23 60.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.743 0.817 . . . . 0.0 111.079 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.77 -28.58 69.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.171 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -87.01 -9.0 56.62 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.969 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.46 HD22 ' SG ' ' A' ' 79' ' ' CYS . 86.7 mt -89.16 129.4 35.76 Favored 'General case' 0 N--CA 1.413 -2.293 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -115.97 159.71 38.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -74.41 145.65 34.18 Favored 'Trans proline' 0 N--CA 1.438 -1.759 0 C-N-CA 121.73 1.62 . . . . 0.0 110.086 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.34 152.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.987 0.422 . . . . 0.0 111.591 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.55 158.11 19.57 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.145 0.498 . . . . 0.0 111.765 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -146.67 102.4 3.55 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.773 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.828 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -73.22 -55.54 6.3 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.7 m -95.12 109.53 21.59 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.642 0.258 . . . . 0.0 111.614 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -73.06 119.79 77.49 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.457 177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -59.67 134.72 59.44 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 122.669 2.246 . . . . 0.0 112.128 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.2 t -77.35 -27.33 52.63 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 91.5 m-70 -133.72 134.28 42.83 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 173.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.6 m -83.0 107.83 15.88 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.42 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 97.4 m95 -104.52 151.63 23.36 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.906 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -128.76 162.23 27.91 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.024 0.44 . . . . 0.0 109.939 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.32 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.589 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.79 8.92 81.99 Favored Glycine 0 C--O 1.243 0.703 0 C-N-CA 121.175 -0.536 . . . . 0.0 113.298 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -92.64 158.92 15.7 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -101.11 129.45 47.0 Favored 'General case' 0 N--CA 1.403 -2.777 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 176.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.2 p -138.0 174.89 10.08 Favored 'General case' 0 C--N 1.258 -3.393 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.716 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.1 mtp -118.34 128.89 55.08 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.54 152.17 36.49 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.3 t -87.5 113.71 25.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -67.63 117.02 9.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -61.8 -16.87 53.41 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.119 0.887 . . . . 0.0 111.681 -175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -83.62 -42.79 16.33 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -106.69 -19.6 13.61 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.077 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.77 13.55 69.49 Favored Glycine 0 C--N 1.313 -0.696 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.228 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -113.91 166.05 11.98 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.282 -0.54 . . . . 0.0 110.645 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 29.2 p -98.97 134.84 41.25 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.343 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -135.37 158.08 45.27 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.52 0.728 . . . . 0.0 109.659 -177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -74.59 124.0 25.85 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.529 0.681 . . . . 0.0 109.83 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.26 151.72 45.35 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.189 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -110.14 134.87 51.75 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.59 126.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.445 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.11 -36.57 10.43 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.109 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -160.15 151.11 19.07 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.8 mt -123.93 138.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 C-N-CA 122.837 0.455 . . . . 0.0 110.055 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -115.26 92.52 3.95 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -65.04 -25.66 67.92 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.429 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -65.87 -43.1 89.34 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.696 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -91.75 -13.74 31.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 121.013 0.435 . . . . 0.0 109.942 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.67 30.11 58.52 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.1 p -114.79 165.26 13.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 120.755 0.312 . . . . 0.0 111.538 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.49 145.2 32.39 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.53 121.46 34.0 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -124.96 151.64 30.72 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.375 -173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.5 m -122.57 123.1 40.42 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -68.95 125.16 25.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.262 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.03 134.89 41.31 Favored 'General case' 0 N--CA 1.433 -1.299 0 O-C-N 124.047 0.842 . . . . 0.0 110.438 -176.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.8 -49.75 2.28 Favored Glycine 0 N--CA 1.435 -1.41 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.84 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -80.77 -50.64 9.59 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.36 5.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 120.496 -0.859 . . . . 0.0 115.207 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -111.22 167.57 10.18 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 118.363 1.081 . . . . 0.0 108.619 174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.99 139.5 36.06 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.2 160.12 41.04 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.89 115.77 38.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -132.15 141.57 41.91 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.398 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 20.2 Cg_endo -60.71 147.91 93.4 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.478 2.119 . . . . 0.0 112.47 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.45 -26.26 60.92 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 124.124 0.97 . . . . 0.0 111.227 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 pp -66.02 -29.31 69.65 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.397 177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -84.71 -12.25 54.18 Favored 'General case' 0 CA--C 1.491 -1.315 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.107 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.491 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -86.49 130.19 34.59 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 121.419 0.628 . . . . 0.0 110.005 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -115.82 155.26 47.9 Favored Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.191 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -70.83 150.34 61.53 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 121.62 1.546 . . . . 0.0 110.532 175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -87.6 177.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -89.84 152.07 21.45 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 174.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 127' ' ' GLU . 0.3 OUTLIER -92.44 156.9 16.88 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 120.751 0.31 . . . . 0.0 110.544 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.671 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 178.286 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 m -152.6 -67.98 0.16 Allowed 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.85 -0.531 . . . . 0.0 110.993 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.5 m -98.46 107.75 20.28 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -80.01 115.3 53.29 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.22 143.23 17.48 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.632 2.221 . . . . 0.0 113.204 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.0 m -77.4 -27.92 52.59 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 121.562 0.696 . . . . 0.0 109.577 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -83.01 125.88 31.92 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.524 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.3 t -101.42 124.74 47.57 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.438 ' HB3' HD13 ' A' ' 94' ' ' ILE . 97.2 m95 -125.66 151.32 46.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -126.58 157.92 37.61 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 120.992 0.425 . . . . 0.0 110.587 172.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.15 132.24 28.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.728 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.52 -6.13 57.38 Favored Glycine 0 N--CA 1.435 -1.403 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.401 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.64 146.29 24.99 Favored 'General case' 0 CA--C 1.466 -2.263 0 CA-C-O 120.626 0.251 . . . . 0.0 110.644 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 93' ' ' GLU 0.277 0.0 OUTLIER -101.49 145.26 29.22 Favored 'General case' 1 N--CA 1.371 -4.386 0 CA-C-O 122.43 1.11 . . . . 0.0 113.125 176.762 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.529 ' SG ' HD22 ' A' ' 122' ' ' LEU . 10.1 p -141.44 179.12 6.98 Favored 'General case' 0 C--N 1.263 -3.158 0 CA-C-N 112.965 -1.925 . . . . 0.0 108.562 -171.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.445 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 47.9 mtp -110.55 129.75 55.72 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.71 152.09 35.95 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.4 t -87.03 113.34 24.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.5 t90 -67.57 116.55 8.42 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -62.24 -18.08 60.19 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 123.886 0.741 . . . . 0.0 111.62 -174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -82.76 -42.21 18.25 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 122.149 -0.345 . . . . 0.0 111.374 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.437 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 20.3 t70 -103.92 -18.96 14.4 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-O 121.412 0.625 . . . . 0.0 111.436 -173.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.03 11.3 84.61 Favored Glycine 0 C--N 1.315 -0.631 0 CA-C-N 115.756 -0.656 . . . . 0.0 113.12 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -115.06 167.48 10.77 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 122.566 -0.373 . . . . 0.0 111.151 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.3 p -95.33 133.97 38.64 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 120.932 0.396 . . . . 0.0 111.601 -177.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -137.89 157.79 45.68 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -77.13 129.6 36.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.552 0.692 . . . . 0.0 110.496 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.92 143.63 33.37 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.06 -178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 34.7 tt0 -100.84 134.58 43.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 120.901 0.382 . . . . 0.0 109.982 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' A' ' 73' ' ' TRP . 71.4 mt -75.18 122.7 29.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.632 -178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -97.7 -34.77 10.8 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.704 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -157.36 151.71 25.0 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.02 147.57 28.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.41 97.92 5.69 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.17 -23.12 67.02 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 0.9 OUTLIER -67.46 -42.24 83.35 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -176.135 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -99.04 -14.2 19.54 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.976 0.417 . . . . 0.0 110.842 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.463 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.88 36.28 61.35 Favored Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -173.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.6 p -114.03 162.09 16.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 120.713 0.292 . . . . 0.0 110.992 -178.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.61 40.38 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.135 0.493 . . . . 0.0 110.221 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.54 36.92 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.51 149.87 30.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.256 -171.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 68.8 m -117.65 122.79 44.51 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -66.59 128.01 34.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.772 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.68 135.48 46.88 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.641 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.8 -48.53 3.88 Favored Glycine 0 C--N 1.3 -1.448 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.994 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -82.38 -49.68 9.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.762 0.281 . . . . 0.0 111.353 -178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.13 22.47 15.11 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.001 -1.095 . . . . 0.0 115.237 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 93.0 m-20 -96.76 166.73 11.5 Favored 'General case' 0 CA--C 1.489 -1.37 0 CA-C-N 118.538 1.169 . . . . 0.0 109.425 175.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.37 133.47 31.14 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.01 160.11 40.97 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -103.45 115.74 45.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -132.48 141.47 41.37 Favored Pre-proline 0 C--N 1.28 -2.439 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.6 Cg_endo -59.96 148.26 89.57 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.448 2.099 . . . . 0.0 111.896 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 70.2 mt -58.06 -25.92 61.86 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.517 0.727 . . . . 0.0 110.983 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.0 pp -65.28 -29.24 69.99 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.166 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -88.49 -8.08 55.46 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.171 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' SG ' ' A' ' 79' ' ' CYS . 84.7 mt -90.1 130.17 36.3 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -115.53 157.1 45.07 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.219 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.65 141.2 49.33 Favored 'Trans proline' 0 N--CA 1.44 -1.64 0 C-N-CA 121.712 1.608 . . . . 0.0 109.289 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.445 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 26.9 m -70.99 152.06 8.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.11 0.481 . . . . 0.0 112.179 -177.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -104.06 151.13 23.62 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.441 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -123.78 37.37 4.43 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.167 -175.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 119.145 -0.809 . . . . 0.0 111.206 -178.449 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.627 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.5 m -66.03 -49.22 68.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 109.389 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.5 m -105.86 125.46 51.02 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -68.07 149.07 98.3 Favored Pre-proline 0 C--N 1.31 -1.126 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.53 157.89 17.5 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 123.523 2.815 . . . . 0.0 112.575 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.3 m -72.38 -15.29 61.85 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.685 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -136.83 162.22 33.84 Favored 'General case' 0 C--O 1.244 0.807 0 O-C-N 121.547 -0.721 . . . . 0.0 111.371 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 41.4 m -112.93 108.05 16.85 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.887 0.875 . . . . 0.0 109.289 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 99.6 m95 -123.23 152.53 41.2 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -125.63 158.87 33.63 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.13 138.08 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.589 178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.56 10.12 82.2 Favored Glycine 0 N--CA 1.436 -1.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.935 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -90.39 164.58 14.26 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -103.65 130.49 51.12 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.513 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.02 176.05 9.05 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.038 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 29.6 mtp -119.23 129.46 54.96 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.39 150.12 40.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.9 t -87.84 114.04 25.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 10.4 t90 -67.86 115.57 7.55 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.0 m -62.0 -16.57 52.49 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 113.206 -1.815 . . . . 0.0 113.135 -175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -84.42 -39.96 18.37 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.936 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 14.9 t70 -108.52 -18.93 13.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.171 0.51 . . . . 0.0 111.91 -171.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.65 9.74 82.64 Favored Glycine 0 C--N 1.314 -0.675 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.47 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -114.04 167.0 11.04 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 117.469 0.634 . . . . 0.0 111.82 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -97.86 134.35 41.13 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.009 0.433 . . . . 0.0 110.837 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -135.94 157.04 47.82 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.006 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -75.46 129.29 37.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.731 0.645 . . . . 0.0 109.657 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.77 152.69 41.56 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.168 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -108.0 135.4 49.43 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -75.5 124.72 34.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.231 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.03 -38.76 12.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.912 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -162.48 151.94 15.73 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.5 mt -121.0 142.49 36.9 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 123.096 0.559 . . . . 0.0 109.938 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -119.0 92.91 3.92 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.45 -17.76 64.8 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.789 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -68.53 -43.14 77.36 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.525 0.678 . . . . 0.0 110.036 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -98.11 -13.92 20.72 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.855 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.76 35.91 49.45 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -114.05 164.46 13.79 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.794 0.331 . . . . 0.0 111.4 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.66 144.62 31.34 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.917 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.84 124.16 36.63 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.3 pp -125.51 154.72 34.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.875 -173.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -123.35 122.94 39.56 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -66.01 123.75 20.69 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.544 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.42 129.57 40.27 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 124.223 0.952 . . . . 0.0 110.665 -176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.35 -59.86 3.0 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.593 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -67.09 -47.21 71.93 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.107 0.479 . . . . 0.0 110.352 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.38 41.78 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.6 m-20 -90.92 165.2 13.71 Favored 'General case' 0 CA--C 1.482 -1.67 0 CA-C-N 118.788 1.294 . . . . 0.0 109.954 177.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -138.19 138.2 38.32 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.86 159.76 43.5 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.17 112.51 31.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -128.62 140.83 39.6 Favored Pre-proline 0 C--N 1.286 -2.165 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.769 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 34.4 Cg_endo -62.84 147.78 94.23 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.298 1.999 . . . . 0.0 111.581 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 82.4 mt -57.72 -26.42 61.74 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.918 0.887 . . . . 0.0 111.241 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.5 pp -64.01 -28.5 69.84 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 123.339 0.656 . . . . 0.0 110.489 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -86.81 -15.81 38.1 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.183 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.8 mt -83.19 130.04 35.06 Favored 'General case' 0 N--CA 1.428 -1.573 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -115.7 158.85 40.91 Favored Pre-proline 0 C--N 1.282 -2.338 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.409 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.19 153.57 62.15 Favored 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 121.443 1.429 . . . . 0.0 109.977 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.3 m -78.42 129.81 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 121.699 0.762 . . . . 0.0 112.368 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -97.64 177.16 5.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -95.62 -6.37 40.32 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.187 0.518 . . . . 0.0 110.489 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.833 0 CA-C-O 118.146 -1.364 . . . . 0.0 109.867 -177.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.4 m -76.13 -31.53 58.67 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.33 0.586 . . . . 0.0 109.855 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -108.88 109.76 20.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.608 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 19.7 mp0 -75.49 116.67 57.03 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.3 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 119' ' ' LEU . 58.8 Cg_endo -74.88 135.32 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.138 1.892 . . . . 0.0 112.028 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 t -91.95 -25.23 18.97 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.399 0.619 . . . . 0.0 109.63 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -82.35 156.94 23.96 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.873 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 9.6 t -118.67 112.38 19.73 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -116.76 150.65 37.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.758 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -131.08 161.84 31.16 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 123.504 0.503 . . . . 0.0 109.815 176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -64.23 133.63 29.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.265 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.44 15.14 60.71 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.52 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.45 159.44 15.14 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HB3' HG11 ' A' ' 125' ' ' VAL . 32.2 mmtp -98.5 130.45 45.09 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.372 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.487 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.3 p -138.6 175.73 9.31 Favored 'General case' 0 C--N 1.274 -2.689 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.302 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.473 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 57.4 mtp -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 173.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.2 152.78 35.01 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -90.15 113.35 26.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 11.7 t90 -66.58 119.1 11.13 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -59.49 -20.86 58.5 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 123.938 0.773 . . . . 0.0 111.499 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -80.28 -42.1 23.75 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 7.5 t70 -107.79 -19.47 13.52 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.636 -173.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.89 18.31 75.33 Favored Glycine 0 C--N 1.318 -0.429 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.046 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.12 166.23 11.84 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.665 -0.315 . . . . 0.0 110.911 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 18.5 p -103.14 133.98 47.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.903 0.382 . . . . 0.0 111.704 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -137.93 158.18 44.87 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 124.119 0.968 . . . . 0.0 108.641 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -74.01 130.87 40.69 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.531 0.681 . . . . 0.0 109.905 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.65 147.65 37.88 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.325 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -105.79 135.17 47.71 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 65.8 mt -76.1 125.09 35.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.644 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -95.83 -37.76 10.6 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.202 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -157.75 152.65 25.42 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.2 mt -122.56 138.84 51.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 C-N-CA 122.909 0.484 . . . . 0.0 110.295 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.53 95.14 4.61 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 175.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.36 -25.84 67.76 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -44.62 88.79 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.51 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.13 -8.99 31.79 Favored 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.297 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 69.53 30.04 71.22 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 38.5 p -114.03 155.96 24.97 Favored 'General case' 0 N--CA 1.433 -1.286 0 O-C-N 122.467 -0.431 . . . . 0.0 111.299 -177.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.64 145.35 49.9 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.78 121.72 32.89 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.29 151.29 31.0 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.914 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.7 m -118.56 126.44 51.99 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.032 176.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -71.29 121.27 18.15 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.21 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.2 125.72 27.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.59 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.34 -45.13 1.5 Allowed Glycine 0 N--CA 1.435 -1.432 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.92 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -88.11 -44.67 10.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 120.837 0.351 . . . . 0.0 111.046 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.04 16.87 36.79 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.15 -1.024 . . . . 0.0 115.162 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -93.15 166.25 12.43 Favored 'General case' 0 CA--C 1.481 -1.703 0 CA-C-N 118.531 1.165 . . . . 0.0 109.478 177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.09 136.67 33.83 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.94 159.96 41.66 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.607 0.567 . . . . 0.0 109.635 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.41 110.51 27.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -128.58 141.57 41.95 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.865 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.2 Cg_endo -61.65 147.55 95.1 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.766 2.311 . . . . 0.0 112.484 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 69' ' ' PRO . 80.8 mt -59.02 -25.5 63.74 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.415 1.086 . . . . 0.0 111.209 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.47 -31.52 72.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.369 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -81.17 -22.81 38.68 Favored 'General case' 0 CA--C 1.495 -1.165 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.103 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.6 mt -76.84 131.34 38.58 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.454 0.645 . . . . 0.0 110.904 -176.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.1 mttt -114.45 160.39 33.13 Favored Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.484 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.46 152.91 49.66 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 121.802 1.668 . . . . 0.0 109.761 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 78' ' ' LYS . 22.4 m -87.55 -178.2 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 120.648 0.261 . . . . 0.0 110.594 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -76.71 82.63 3.33 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.01 0.91 . . . . 0.0 109.509 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.94 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 113.074 -1.875 . . . . 0.0 106.721 -174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -3.005 0 CA-C-N 113.612 -1.631 . . . . 0.0 110.83 179.127 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.4 m 69.16 -77.1 0.05 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.286 1.034 . . . . 0.0 111.72 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -176.06 136.91 0.3 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -99.14 132.96 22.52 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.93 152.53 57.37 Favored 'Trans proline' 0 C--O 1.24 0.621 0 C-N-CA 122.492 2.128 . . . . 0.0 110.735 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -85.18 3.59 38.44 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.021 0.439 . . . . 0.0 110.563 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.491 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 40.2 m170 -78.54 122.6 26.09 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.7 m -99.61 116.64 32.18 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.491 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.3 m95 -124.11 151.06 44.34 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.186 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -125.08 157.99 34.92 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.04 127.76 25.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.48 -7.81 40.04 Favored Glycine 0 N--CA 1.429 -1.799 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.416 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' HB2' HD12 ' A' ' 94' ' ' ILE . 5.3 m-20 -73.57 146.33 44.83 Favored 'General case' 0 CA--C 1.481 -1.698 0 CA-C-O 121.288 0.566 . . . . 0.0 111.879 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -94.74 130.47 41.25 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.467 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.4 p -140.16 176.9 8.37 Favored 'General case' 0 C--N 1.255 -3.518 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 51.7 mtp -120.24 129.39 54.04 Favored 'General case' 0 C--N 1.275 -2.646 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.57 152.76 35.41 Favored 'General case' 0 C--N 1.281 -2.387 0 O-C-N 123.741 0.65 . . . . 0.0 109.272 -176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.9 t -87.98 113.79 25.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -68.21 115.74 8.02 Favored 'General case' 0 CA--C 1.452 -2.817 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.4 m -60.47 -17.35 44.38 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 113.248 -1.797 . . . . 0.0 113.625 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -84.97 -41.86 15.46 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -107.63 -19.22 13.62 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.055 -173.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.39 12.26 76.17 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.73 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -111.5 168.52 9.48 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 122.319 -0.518 . . . . 0.0 110.328 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.4 p -101.66 134.29 45.03 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.079 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -136.08 157.47 46.74 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.447 0.699 . . . . 0.0 110.042 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.08 126.61 30.9 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.537 0.684 . . . . 0.0 110.502 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.37 149.95 38.44 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.408 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -106.73 139.21 41.52 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.458 HD12 ' HB2' ' A' ' 77' ' ' ASP . 73.7 mt -77.19 121.79 30.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.014 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -93.47 -35.67 12.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.683 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -160.45 151.57 19.08 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.4 mt -122.18 139.61 48.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 122.611 0.364 . . . . 0.0 110.418 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -117.61 93.36 4.13 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -65.76 -17.73 64.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.71 -42.93 69.97 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.031 0.444 . . . . 0.0 110.477 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -99.79 -8.76 23.78 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.138 0.494 . . . . 0.0 110.13 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.54 32.7 61.67 Favored Glycine 0 N--CA 1.425 -2.069 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 17.7 p -113.72 163.98 14.31 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 120.858 0.361 . . . . 0.0 111.563 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.96 144.7 37.17 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.15 121.52 34.6 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.11 151.11 30.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.325 -172.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -119.23 122.91 43.02 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -66.93 118.78 10.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.176 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.7 133.07 46.3 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.012 -175.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.2 -50.55 1.67 Allowed Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.861 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -80.88 -49.53 10.92 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.376 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.27 25.71 10.03 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 115.461 0.945 . . . . 0.0 115.461 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' THR . 77.5 m-20 -104.1 164.86 11.43 Favored 'General case' 0 CA--C 1.48 -1.72 0 CA-C-N 118.961 1.381 . . . . 0.0 109.756 175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -134.44 140.38 46.21 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -149.07 158.79 44.46 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.61 112.72 32.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.4 t -127.66 140.97 39.57 Favored Pre-proline 0 C--N 1.282 -2.327 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.653 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 24.4 Cg_endo -61.64 146.51 96.76 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.37 2.047 . . . . 0.0 111.826 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 78.0 mt -57.05 -26.37 60.23 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 123.702 0.801 . . . . 0.0 110.446 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pp -64.81 -30.22 71.22 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.003 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.17 -6.99 56.52 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.764 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.467 HD22 ' SG ' ' A' ' 79' ' ' CYS . 76.2 mt -85.7 131.9 34.25 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-O 121.024 0.44 . . . . 0.0 110.076 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 64.9 mttm -114.22 157.68 41.68 Favored Pre-proline 0 C--N 1.293 -1.888 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.71 146.02 29.73 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.748 1.632 . . . . 0.0 109.255 172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 m -73.96 159.98 5.43 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.919 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.73 147.53 41.29 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.41 109.27 14.66 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.397 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.667 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -71.52 -41.01 69.74 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -108.37 134.41 51.22 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -96.88 151.84 38.04 Favored Pre-proline 0 C--N 1.305 -1.348 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.268 -177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -49.72 133.98 33.51 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 123.447 2.765 . . . . 0.0 112.902 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -80.33 -31.85 37.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.954 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.476 ' HB2' ' NE1' ' A' ' 73' ' ' TRP . 70.5 m-70 -136.65 162.49 32.99 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.4 m -95.44 109.55 21.72 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.476 ' NE1' ' HB2' ' A' ' 71' ' ' HIS . 96.4 m95 -121.04 144.77 48.36 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.776 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -128.27 165.31 20.75 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.845 0.355 . . . . 0.0 110.09 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.9 t -63.25 127.62 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.24 49.46 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.235 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -77.5 149.55 34.96 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.204 0.526 . . . . 0.0 111.552 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -96.13 131.2 42.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 174.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.6 p -140.77 171.19 14.44 Favored 'General case' 0 C--N 1.256 -3.499 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 43.9 mtp -113.24 129.63 56.47 Favored 'General case' 0 C--N 1.269 -2.892 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.85 151.53 37.18 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 113.68 24.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -68.11 116.13 8.39 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.9 t -63.19 -17.13 62.08 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 123.911 0.757 . . . . 0.0 111.569 -175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -80.41 -39.65 27.91 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 122.097 -0.377 . . . . 0.0 111.46 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -108.38 -19.18 13.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.947 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.44 10.95 82.78 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 116.101 -0.5 . . . . 0.0 113.213 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -114.91 169.29 9.19 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.561 -0.376 . . . . 0.0 111.279 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 20.0 p -99.61 134.27 42.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.975 0.416 . . . . 0.0 111.696 -177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -135.91 157.95 45.6 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.226 1.01 . . . . 0.0 108.99 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.83 127.31 32.48 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 121.794 0.807 . . . . 0.0 110.931 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.43 149.85 39.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.678 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -107.22 135.18 49.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.1 mt -75.41 121.06 26.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.059 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -97.28 -38.78 9.54 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.61 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -154.46 147.31 24.42 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.6 mt -121.26 125.18 73.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.66 91.38 5.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -66.53 -18.34 65.31 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.295 -176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 6.5 tp10 -71.27 -42.74 68.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.452 0.644 . . . . 0.0 109.64 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -96.23 -12.29 24.8 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.448 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.68 28.06 63.9 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.5 p -114.02 155.93 25.02 Favored 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 122.329 -0.512 . . . . 0.0 110.892 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -130.75 142.41 50.41 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.451 . . . . 0.0 110.135 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.71 120.8 31.29 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.27 146.41 31.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 -173.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 85.6 m -117.67 123.24 45.62 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -70.15 117.13 11.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.635 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.97 136.29 57.76 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 124.268 0.98 . . . . 0.0 110.545 -177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.0 -57.62 4.31 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.287 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -72.56 -43.13 63.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.6 21.46 37.16 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 115.041 0.776 . . . . 0.0 115.041 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' THR . 96.7 m-20 -95.85 163.77 13.02 Favored 'General case' 0 CA--C 1.47 -2.107 0 CA-C-N 118.57 1.185 . . . . 0.0 109.969 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.52 133.19 30.51 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.54 155.16 46.7 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.5 t -96.12 110.41 24.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.3 t -126.91 141.19 39.8 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 32.3 Cg_endo -61.23 149.16 90.6 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.683 2.255 . . . . 0.0 112.261 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 80.6 mt -58.84 -26.12 63.88 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 123.711 0.805 . . . . 0.0 111.313 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.33 -28.26 69.18 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.56 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -87.54 -7.37 57.64 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.226 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.474 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.0 mt -88.8 131.33 35.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.287 0.565 . . . . 0.0 110.272 -179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 89.0 mttt -114.37 156.11 44.87 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.98 146.31 29.13 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 121.917 1.745 . . . . 0.0 109.61 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.2 m -76.86 137.33 22.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.38 137.34 36.51 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -107.33 98.16 7.82 Favored 'General case' 0 C--N 1.271 -2.845 0 CA-C-O 121.575 0.702 . . . . 0.0 110.442 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.236 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -179.901 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.458 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.1 m -74.2 -51.01 16.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 120.903 0.382 . . . . 0.0 110.783 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.494 ' HB ' HD22 ' A' ' 120' ' ' LEU . 6.3 m -68.45 128.85 38.1 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.648 -176.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -83.62 126.62 70.65 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.29 134.13 26.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.77 1.647 . . . . 0.0 112.518 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -107.98 -6.88 16.36 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -83.8 127.53 33.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.166 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 m -102.59 114.19 28.19 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.6 m95 -116.78 152.06 35.16 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -174.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -129.85 159.16 37.44 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.334 0.587 . . . . 0.0 112.165 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 136.73 25.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.748 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.6 9.95 65.93 Favored Glycine 0 CA--C 1.5 -0.875 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.182 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.78 154.12 21.99 Favored 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -91.59 138.63 31.42 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.863 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.1 p -145.13 178.0 8.38 Favored 'General case' 0 C--N 1.259 -3.365 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.142 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 63.5 mtp -119.6 129.96 54.88 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 173.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.23 151.57 37.39 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -87.34 114.05 25.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.5 t90 -66.07 116.57 7.32 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.8 t -61.82 -16.19 48.04 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 124.187 0.995 . . . . 0.0 111.782 -176.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 18.3 mm-40 -83.7 -41.57 17.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.134 -0.354 . . . . 0.0 111.365 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -107.58 -20.85 13.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.339 -172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.27 13.23 79.3 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -114.74 167.38 10.81 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.1 -0.647 . . . . 0.0 110.67 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 28.3 p -99.76 134.83 42.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -135.93 157.92 45.66 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.46 1.104 . . . . 0.0 108.829 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -74.23 129.22 37.4 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.505 0.669 . . . . 0.0 110.54 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.26 156.58 44.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.56 137.89 50.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 73' ' ' TRP . 64.8 mt -76.88 121.28 28.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 123.733 0.646 . . . . 0.0 111.181 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -97.92 -36.78 10.04 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.317 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -156.0 149.46 24.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.9 mt -123.48 125.32 71.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.93 90.95 5.1 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 175.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.12 -19.11 65.74 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.96 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -67.28 -42.94 82.95 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.009 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -99.08 -14.08 19.56 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.461 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.29 33.04 45.65 Favored Glycine 0 N--CA 1.433 -1.512 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 20.8 p -114.24 162.91 15.96 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 122.759 0.424 . . . . 0.0 110.23 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.417 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.19 143.16 40.09 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 177.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.9 119.91 32.68 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.54 149.07 30.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.648 -172.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.5 m -113.65 122.75 48.13 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -67.34 121.97 16.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.458 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.24 125.29 24.07 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 124.512 1.133 . . . . 0.0 111.023 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 92.79 -51.0 2.59 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.659 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -73.43 -49.57 26.26 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.804 0.335 . . . . 0.0 110.737 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.95 21.16 19.1 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.153 -1.023 . . . . 0.0 115.264 177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -96.99 164.64 12.44 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-N 118.355 1.078 . . . . 0.0 108.838 175.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.4 133.58 31.23 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -140.23 159.88 41.21 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.01 110.47 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -125.58 141.2 38.37 Favored Pre-proline 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.202 -173.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.1 Cg_endo -60.06 147.16 94.19 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.529 2.153 . . . . 0.0 112.288 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.7 mt -56.59 -26.57 55.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.886 0.875 . . . . 0.0 111.236 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.494 HD22 ' HB ' ' A' ' 67' ' ' THR . 1.9 pp -64.87 -29.08 70.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-O 121.541 0.686 . . . . 0.0 110.158 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -89.92 -3.92 57.79 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.491 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.436 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.6 mt -93.54 130.44 39.41 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.442 0.639 . . . . 0.0 109.638 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -115.6 158.36 41.99 Favored Pre-proline 0 C--N 1.289 -2.03 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.594 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -68.89 149.84 72.78 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.499 -1.385 . . . . 0.0 108.499 171.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.6 m -67.44 119.89 13.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.861 0.839 . . . . 0.0 112.411 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.677 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 12.3 pt-20 -98.01 22.95 8.66 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.874 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 65.57 25.44 11.71 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.009 -1.451 . . . . 0.0 111.401 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.109 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 178.892 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.716 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m -115.98 7.43 14.36 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.793 0.33 . . . . 0.0 111.607 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.5 p -98.35 166.15 11.52 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.873 0.368 . . . . 0.0 111.636 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -74.26 126.66 88.83 Favored Pre-proline 0 N--CA 1.432 -1.336 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.15 153.31 56.99 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 122.431 2.087 . . . . 0.0 112.353 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -99.38 -13.84 19.42 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -97.2 120.91 38.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.487 -0.778 . . . . 0.0 109.482 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 m -96.73 117.53 31.23 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.416 ' HB3' HD13 ' A' ' 94' ' ' ILE . 89.0 m95 -118.36 145.29 45.25 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.237 -176.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 ptmm? -129.21 164.24 23.85 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 173.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -61.98 133.75 27.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.746 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.09 17.51 59.18 Favored Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.29 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -97.39 152.47 18.91 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.003 0.43 . . . . 0.0 111.419 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.36 131.33 40.12 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.479 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.6 p -144.1 175.73 9.84 Favored 'General case' 0 C--N 1.256 -3.488 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 122' ' ' LEU . 46.8 mtp -116.93 129.32 55.97 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.33 150.31 39.71 Favored 'General case' 0 C--N 1.282 -2.366 0 O-C-N 123.961 0.788 . . . . 0.0 109.01 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -87.18 113.4 24.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.52 118.74 10.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.4 t -56.89 -24.26 50.62 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 124.483 1.114 . . . . 0.0 111.363 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -84.35 -39.33 19.23 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -105.97 -19.95 13.58 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.388 -175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.84 11.15 83.16 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.001 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -114.86 167.33 10.88 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.427 -0.455 . . . . 0.0 111.162 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.5 p -100.64 134.63 43.32 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.259 0.552 . . . . 0.0 112.123 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -132.63 158.66 41.69 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.357 1.063 . . . . 0.0 109.201 -176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.55 126.64 30.7 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.64 0.733 . . . . 0.0 109.929 -178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.16 149.45 38.06 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.981 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -108.09 135.72 48.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 73' ' ' TRP . 65.7 mt -76.65 123.05 32.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.937 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -95.17 -36.08 11.61 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.544 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -157.9 151.45 23.64 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.64 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.0 mt -125.6 125.91 69.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.25 0.548 . . . . 0.0 109.551 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -102.81 91.89 4.36 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -66.43 -18.2 65.23 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.979 -1.009 . . . . 0.0 112.492 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.6 -42.79 86.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.284 0.564 . . . . 0.0 109.888 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -102.33 -13.93 17.14 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.49 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 75.04 32.4 56.57 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -175.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 46.5 p -114.44 157.38 22.97 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 122.37 -0.488 . . . . 0.0 110.769 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.414 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -128.4 141.65 51.35 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-O 121.052 0.453 . . . . 0.0 110.045 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.08 119.18 33.15 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.4 pp -125.18 153.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 -171.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.6 m -120.75 123.27 42.27 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -69.74 122.92 20.13 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.814 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.3 134.2 48.82 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 124.364 1.04 . . . . 0.0 110.666 -175.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.36 -50.25 3.28 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 121.201 -0.524 . . . . 0.0 112.472 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -76.59 -50.12 14.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 122.68 -0.306 . . . . 0.0 110.26 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.2 46.1 3.38 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.421 -0.895 . . . . 0.0 113.972 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 91.7 m-20 -118.85 165.99 13.36 Favored 'General case' 0 CA--C 1.482 -1.656 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 172.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.75 133.41 28.77 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 123.481 0.488 . . . . 0.0 109.769 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -143.04 159.94 41.31 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.258 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.2 t -99.05 111.3 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.9 t -128.88 140.83 39.72 Favored Pre-proline 0 C--N 1.283 -2.3 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -176.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 28.3 Cg_endo -60.68 149.84 85.41 Favored 'Trans proline' 0 C--O 1.237 0.447 0 C-N-CA 122.707 2.271 . . . . 0.0 111.848 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 74.0 mt -57.34 -26.56 61.15 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.373 0.669 . . . . 0.0 111.275 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.2 pp -63.48 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.526 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -85.88 -5.94 59.16 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.181 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -93.77 130.26 39.83 Favored 'General case' 0 N--CA 1.411 -2.381 0 CA-C-O 121.564 0.697 . . . . 0.0 109.779 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -115.43 153.49 47.62 Favored Pre-proline 0 N--CA 1.416 -2.145 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.42 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -61.84 149.68 89.11 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 C-N-CA 121.852 1.701 . . . . 0.0 107.967 169.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.03 120.47 14.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.757 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -100.6 128.79 46.54 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.73 0.776 . . . . 0.0 110.969 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -95.73 -21.67 18.02 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.53 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.402 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 178.857 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.695 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.4 m -78.59 -50.99 10.56 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.7 m -92.03 106.71 18.67 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 114.199 -1.364 . . . . 0.0 107.669 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.65 146.04 36.41 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -60.9 146.62 97.33 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.794 2.33 . . . . 0.0 112.15 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -76.59 -13.29 60.08 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.546 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 55.0 m170 -58.55 120.13 8.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 174.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -104.82 116.35 31.85 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.546 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 99.1 m95 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.425 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -129.18 163.71 24.98 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 123.395 0.434 . . . . 0.0 110.116 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.42 128.25 25.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.45 -8.68 48.26 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.302 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.95 145.68 35.94 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.142 0.496 . . . . 0.0 111.2 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.0 mmtt -91.91 131.28 37.35 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.524 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.8 p -140.98 175.75 9.36 Favored 'General case' 0 C--N 1.269 -2.923 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.407 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 37.6 mtp -116.62 129.05 55.93 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.94 151.71 37.66 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.5 t -88.13 114.18 26.33 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -66.19 118.29 9.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.1 t -56.09 -24.06 37.9 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 124.326 1.016 . . . . 0.0 111.502 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -82.35 -42.65 18.43 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -105.75 -19.62 13.7 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 118.974 -1.09 . . . . 0.0 111.695 -174.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.82 15.98 73.94 Favored Glycine 0 C--N 1.312 -0.757 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.778 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -114.56 166.56 11.59 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 122.57 -0.371 . . . . 0.0 111.468 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 22.3 p -98.07 134.67 40.83 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.024 0.44 . . . . 0.0 111.813 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.37 158.3 44.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 123.806 0.843 . . . . 0.0 109.232 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -73.27 127.37 32.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.11 145.33 37.46 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.824 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -105.72 135.42 47.17 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.09 121.78 25.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.089 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -95.95 -40.4 9.3 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.569 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.52 147.99 27.49 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -175.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.0 mt -125.81 131.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.183 0.515 . . . . 0.0 110.373 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -105.09 94.5 5.27 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.68 -18.11 65.2 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.193 -178.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -67.13 -43.69 81.76 Favored 'General case' 0 N--CA 1.442 -0.838 0 O-C-N 123.751 0.657 . . . . 0.0 110.298 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -101.48 -14.15 17.63 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.152 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 77.17 35.87 36.88 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.3 p -114.04 157.56 22.37 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.189 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.15 142.3 40.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 121.289 0.566 . . . . 0.0 110.61 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.59 121.69 34.28 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.15 148.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.308 -172.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 76.3 m -114.04 125.25 53.78 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -69.48 117.8 11.55 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.885 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.68 134.73 53.84 Favored 'General case' 0 N--CA 1.434 -1.231 0 O-C-N 124.592 1.183 . . . . 0.0 110.438 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.23 -60.31 1.92 Allowed Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -73.49 -50.16 22.95 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.812 0.339 . . . . 0.0 110.794 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.91 15.34 26.69 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 115.706 1.042 . . . . 0.0 115.706 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' THR . 97.0 m-20 -89.47 163.93 15.04 Favored 'General case' 0 CA--C 1.482 -1.658 0 CA-C-N 119.251 1.525 . . . . 0.0 109.86 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.67 133.46 34.3 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.44 159.38 42.33 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.5 t -100.87 111.11 29.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 t -127.47 141.05 39.71 Favored Pre-proline 0 C--N 1.28 -2.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.1 Cg_endo -60.7 148.41 91.76 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.52 2.147 . . . . 0.0 112.519 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 78.6 mt -56.26 -26.2 50.8 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.912 0.885 . . . . 0.0 111.216 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.6 pp -64.94 -31.64 72.97 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.482 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 66.9 m-20 -82.4 -16.18 50.0 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.177 -178.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.524 HD22 ' SG ' ' A' ' 79' ' ' CYS . 81.4 mt -83.2 130.93 35.13 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.206 0.527 . . . . 0.0 110.695 -177.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 61.4 mttp -115.13 155.66 46.42 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.761 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -73.48 148.6 42.98 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.2 1.933 . . . . 0.0 110.766 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.3 m -88.58 154.86 3.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.53 143.69 29.16 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -80.6 85.54 5.99 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.232 0.539 . . . . 0.0 110.491 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 178.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.7 m 69.84 15.62 7.89 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.477 1.111 . . . . 0.0 112.469 177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.2 t -168.78 172.15 8.06 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.07 137.74 23.57 Favored Pre-proline 0 C--N 1.307 -1.263 0 O-C-N 123.334 0.396 . . . . 0.0 109.978 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.26 151.01 70.61 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.345 2.03 . . . . 0.0 110.35 174.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 m -73.06 -33.28 65.57 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.216 0.532 . . . . 0.0 109.793 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -142.08 153.09 43.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 m -87.64 110.62 20.53 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.352 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -124.22 150.91 44.72 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.82 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -132.38 163.83 27.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.996 0.427 . . . . 0.0 110.846 174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.7 t -63.91 137.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 C-N-CA 123.942 0.897 . . . . 0.0 111.218 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.4 5.06 70.07 Favored Glycine 0 CA--C 1.502 -0.752 0 C-N-CA 121.457 -0.402 . . . . 0.0 112.652 177.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.23 153.67 19.41 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 121.156 0.503 . . . . 0.0 112.02 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HB3' HG11 ' A' ' 125' ' ' VAL . 32.8 mmtp -92.29 141.5 28.49 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.728 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.52 ' SG ' HD22 ' A' ' 122' ' ' LEU . 19.8 p -148.55 176.25 10.48 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 39.5 mtp -114.33 129.28 56.64 Favored 'General case' 0 N--CA 1.409 -2.517 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 174.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.0 151.21 37.91 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.47 113.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.43 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.2 t90 -66.91 115.51 6.74 Favored 'General case' 0 CA--C 1.483 -1.63 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -59.71 -18.04 39.37 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 124.277 0.985 . . . . 0.0 111.442 -175.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -85.08 -42.18 15.05 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 32.0 t70 -105.47 -18.71 14.01 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.211 0.529 . . . . 0.0 111.791 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.57 11.34 83.2 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.764 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -114.39 167.83 10.37 Favored 'General case' 0 C--N 1.316 -0.855 0 O-C-N 122.594 -0.356 . . . . 0.0 111.037 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 6.6 p -94.17 134.07 37.0 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.026 0.441 . . . . 0.0 111.061 -177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -138.0 157.53 46.18 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.17 124.18 25.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.508 0.67 . . . . 0.0 110.327 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.03 148.07 46.59 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.287 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.39 132.68 50.36 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 76.4 mt -72.39 122.72 25.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.279 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -91.91 -41.09 10.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.294 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -160.58 152.4 19.87 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mt -122.08 132.26 71.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -104.36 91.82 4.07 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.83 -23.19 66.63 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.855 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.79 -42.38 99.68 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.439 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.31 -14.5 18.38 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.506 177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.32 32.32 43.46 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 34.1 p -113.7 160.9 18.14 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 122.546 -0.385 . . . . 0.0 110.756 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.14 141.04 45.87 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.993 0.425 . . . . 0.0 110.121 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.62 122.23 32.56 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.39 150.62 30.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.267 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -122.24 123.33 41.22 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.175 0.512 . . . . 0.0 109.763 176.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -66.27 130.71 44.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.769 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.93 136.66 43.32 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.033 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.12 -57.45 4.28 Favored Glycine 0 N--CA 1.438 -1.203 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -75.74 -48.2 22.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.796 0.332 . . . . 0.0 110.481 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.76 20.4 28.97 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 116.057 1.183 . . . . 0.0 116.057 175.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 107' ' ' THR . 71.0 m-20 -95.57 161.05 14.21 Favored 'General case' 0 CA--C 1.485 -1.532 0 CA-C-N 118.933 1.366 . . . . 0.0 109.503 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -131.79 134.2 45.56 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 123.338 0.399 . . . . 0.0 110.321 -176.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -143.84 160.07 41.43 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.46 112.32 36.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.5 t -129.62 141.32 41.41 Favored Pre-proline 0 C--N 1.29 -2.005 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.323 -175.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 27.2 Cg_endo -59.68 149.43 82.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.81 2.34 . . . . 0.0 113.02 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 87.9 mt -59.21 -25.95 64.42 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.687 0.795 . . . . 0.0 111.123 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.3 pp -64.14 -31.17 72.26 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.19 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -84.34 -16.56 42.49 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.736 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.52 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.6 mt -81.94 130.39 35.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 121.373 0.606 . . . . 0.0 110.494 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.4 mttp -115.23 160.81 32.66 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 115.096 -0.957 . . . . 0.0 109.433 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 153.98 55.39 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.842 1.695 . . . . 0.0 110.874 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 78' ' ' LYS . 30.4 m -93.17 173.98 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-O 120.966 0.413 . . . . 0.0 111.805 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.99 139.78 46.05 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -127.07 132.51 50.65 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.041 0.448 . . . . 0.0 111.605 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.833 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 176.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.6 m -70.64 -49.26 49.29 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 120.703 0.287 . . . . 0.0 111.224 -177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.0 p -111.32 143.33 42.29 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -87.83 123.61 68.78 Favored Pre-proline 0 N--CA 1.433 -1.299 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.36 135.34 69.65 Favored 'Trans proline' 0 C--O 1.241 0.662 0 C-N-CA 122.685 2.257 . . . . 0.0 111.637 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -76.35 -10.39 59.37 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.443 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 67.5 m80 -104.68 122.7 46.2 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.3 m -96.48 114.55 26.22 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.241 0.543 . . . . 0.0 109.911 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 93.6 m95 -120.68 151.6 39.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.559 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -134.56 162.15 33.09 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.58 131.26 30.3 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.1 17.42 59.3 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.044 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -99.37 155.78 17.35 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -99.34 130.15 45.6 Favored 'General case' 0 C--N 1.27 -2.887 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.492 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.5 p -137.2 173.95 11.13 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.548 ' SD ' ' HG2' ' A' ' 126' ' ' GLU . 40.6 mtp -115.02 129.43 56.71 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.51 149.61 40.31 Favored 'General case' 0 C--N 1.275 -2.663 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.1 t -87.78 113.54 25.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -66.41 115.4 6.29 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.8 t -60.93 -17.24 50.1 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 124.107 0.879 . . . . 0.0 111.622 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -81.72 -39.45 24.23 Favored 'General case' 0 N--CA 1.441 -0.889 0 O-C-N 122.142 -0.349 . . . . 0.0 111.545 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -110.53 -19.73 12.81 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.155 0.503 . . . . 0.0 112.237 -172.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.93 15.07 79.85 Favored Glycine 0 C--N 1.309 -0.951 0 CA-C-N 116.177 -0.465 . . . . 0.0 113.975 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -114.75 168.13 10.15 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 117.236 0.518 . . . . 0.0 111.15 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 28.1 p -98.28 134.59 41.09 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.147 0.499 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -136.42 158.71 43.78 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.123 0.969 . . . . 0.0 108.83 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -73.32 124.4 25.64 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.511 0.672 . . . . 0.0 109.344 -178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.83 141.64 38.68 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.688 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.72 136.13 43.98 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.6 mt -75.83 120.49 25.79 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.999 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -91.85 -36.72 13.34 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.133 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -158.8 152.43 23.13 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -176.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.0 mt -120.59 131.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -112.42 92.33 3.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 -27.66 68.55 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.371 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -61.33 -43.23 99.23 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.724 0.64 . . . . 0.0 110.848 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -97.92 -14.09 20.85 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.043 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.65 28.28 57.5 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 22.9 p -114.5 163.46 15.33 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.034 0.445 . . . . 0.0 111.457 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.75 143.99 49.97 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.87 120.96 34.82 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.06 149.12 29.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.851 -172.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.4 m -116.65 126.23 52.91 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -72.12 120.49 17.79 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.895 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.89 131.11 45.22 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 124.288 0.993 . . . . 0.0 110.963 -176.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.56 -58.57 2.24 Favored Glycine 0 N--CA 1.431 -1.653 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.673 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -70.18 -43.94 69.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 91.92 23.5 27.61 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.206 -0.997 . . . . 0.0 114.911 177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -98.38 168.78 10.0 Favored 'General case' 0 CA--C 1.482 -1.664 0 CA-C-N 118.456 1.128 . . . . 0.0 109.433 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -140.68 144.09 35.46 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -150.82 159.54 44.47 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.1 t -102.66 113.35 39.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -129.54 141.09 40.6 Favored Pre-proline 0 C--N 1.283 -2.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.213 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 22.0 Cg_endo -59.2 149.04 83.08 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.855 2.37 . . . . 0.0 112.766 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 76.5 mt -58.98 -26.55 64.59 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.531 0.732 . . . . 0.0 110.963 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pp -64.88 -29.58 70.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.454 177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -87.84 -8.24 56.14 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.423 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.492 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -88.64 131.01 35.16 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.322 0.582 . . . . 0.0 109.833 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -115.07 154.88 47.18 Favored Pre-proline 0 C--N 1.288 -2.075 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.625 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -70.0 146.5 58.86 Favored 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.321 1.347 . . . . 0.0 108.902 173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.3 m -68.68 129.37 33.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.523 0.677 . . . . 0.0 112.19 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.548 ' HG2' ' SD ' ' A' ' 80' ' ' MET . 10.0 pt-20 -97.77 144.94 26.86 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.403 176.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -133.43 14.86 4.11 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.82 0.819 . . . . 0.0 109.671 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.223 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.715 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.036 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 m -74.62 -43.57 54.79 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-O 120.938 0.399 . . . . 0.0 109.956 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 p -134.24 144.05 48.18 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -89.3 125.38 62.02 Favored Pre-proline 0 N--CA 1.416 -2.132 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.47 157.7 60.52 Favored 'Trans proline' 0 C--O 1.24 0.595 0 C-N-CA 123.237 2.625 . . . . 0.0 112.075 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.7 m -74.79 -29.99 61.28 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -103.79 147.27 27.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 m -98.84 106.43 18.7 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 171.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.404 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.5 m95 -92.04 150.96 20.69 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.585 -174.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -130.03 158.19 40.29 Favored 'General case' 0 C--N 1.311 -1.078 0 O-C-N 123.35 0.406 . . . . 0.0 109.929 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.0 t -63.99 132.49 29.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.635 176.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.68 9.86 63.93 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.88 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -94.48 167.33 11.57 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -105.35 129.84 53.59 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.7 p -139.06 173.46 11.54 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.668 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.465 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 48.6 mtp -116.16 131.69 56.87 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -117.86 152.03 36.2 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.5 t -87.33 113.67 25.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CD2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -67.55 116.84 8.73 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.6 t -58.95 -16.75 19.37 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 124.423 1.089 . . . . 0.0 111.431 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 83' ' ' TRP . 24.7 mm-40 -84.62 -42.57 15.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -108.68 -19.6 13.37 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 119.954 -0.698 . . . . 0.0 112.129 -172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.04 10.36 82.94 Favored Glycine 0 C--N 1.315 -0.623 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.99 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -113.87 164.55 13.61 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.313 -0.522 . . . . 0.0 111.078 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 24.7 p -97.03 134.42 40.41 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 123.289 0.368 . . . . 0.0 111.454 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 80' ' ' MET . 66.2 m-85 -136.44 158.32 44.71 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 124.002 0.921 . . . . 0.0 108.865 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -72.61 130.82 41.47 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.507 0.67 . . . . 0.0 109.938 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.54 151.97 39.87 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.51 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.82 134.8 51.03 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 73' ' ' TRP . 68.2 mt -74.08 121.56 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.83 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -92.98 -35.96 13.01 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.707 -177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -159.53 151.43 20.55 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.1 mt -121.94 131.46 73.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -105.16 90.6 3.49 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -65.77 -20.51 66.29 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.697 -175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -72.59 -43.02 63.93 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.385 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -91.9 -14.59 29.37 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.782 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.96 33.88 49.18 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 11.4 p -114.36 164.84 13.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 122.899 0.48 . . . . 0.0 110.98 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.88 145.11 37.61 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.011 0.434 . . . . 0.0 110.005 177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.01 121.47 38.93 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.28 155.35 34.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.441 -172.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.9 m -121.71 127.28 50.55 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -72.59 116.94 13.67 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.859 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.82 133.63 55.71 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 124.619 1.199 . . . . 0.0 110.821 -176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.27 -54.74 3.57 Favored Glycine 0 N--CA 1.434 -1.444 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.604 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -73.1 -49.3 29.22 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.13 26.58 11.11 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.705 -0.76 . . . . 0.0 114.688 176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -103.05 165.55 10.96 Favored 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 118.307 1.053 . . . . 0.0 108.75 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 138.38 39.4 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.06 0.225 . . . . 0.0 110.451 -177.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.17 159.97 43.0 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.08 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.75 114.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -132.41 140.81 39.09 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.4 Cg_endo -60.1 148.97 87.35 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.705 2.27 . . . . 0.0 112.47 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 88.4 mt -59.12 -25.94 64.28 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.698 0.799 . . . . 0.0 111.079 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.97 -32.42 73.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.264 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -83.29 -12.78 56.33 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.539 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -84.38 130.36 34.79 Favored 'General case' 0 N--CA 1.423 -1.825 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.2 mttm -114.45 159.07 38.24 Favored Pre-proline 0 C--N 1.29 -2.006 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.74 151.46 36.33 Favored 'Trans proline' 0 N--CA 1.439 -1.682 0 C-N-CA 121.294 1.329 . . . . 0.0 110.239 176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.1 m -82.3 138.88 18.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.3 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -103.83 166.6 10.31 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.569 0.7 . . . . 0.0 110.495 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.14 8.09 5.54 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.187 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.882 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.617 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -81.32 -24.51 37.12 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.489 -0.757 . . . . 0.0 112.009 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.7 m -94.21 108.69 20.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.478 -174.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -100.0 104.12 26.84 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.77 144.56 78.07 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 122.66 2.24 . . . . 0.0 112.88 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.445 HG23 ' CD2' ' A' ' 71' ' ' HIS . 8.8 t -99.21 -11.25 21.5 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.745 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' CD2' HG23 ' A' ' 70' ' ' THR . 97.6 m-70 -120.64 132.78 55.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.184 -0.323 . . . . 0.0 110.412 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.8 t -97.33 114.72 26.55 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.955 0.407 . . . . 0.0 110.377 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' HB3' HD13 ' A' ' 94' ' ' ILE . 98.8 m95 -122.84 152.12 41.03 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.681 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -130.41 155.49 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.463 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.99 134.45 28.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.595 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.47 2.42 63.57 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.189 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.58 152.82 18.28 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HE3' HG21 ' A' ' 125' ' ' VAL . 60.8 pttt -105.9 131.58 53.04 Favored 'General case' 0 N--CA 1.379 -3.985 0 CA-C-O 122.323 1.059 . . . . 0.0 110.884 176.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 122' ' ' LEU . 15.6 p -129.45 175.53 8.69 Favored 'General case' 0 C--N 1.246 -3.924 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.423 -177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.563 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 4.4 mmt -102.12 128.75 48.46 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -127.83 144.09 51.1 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 123.702 0.626 . . . . 0.0 109.858 -176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -87.79 114.23 26.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -68.36 117.45 10.16 Favored 'General case' 0 CA--C 1.463 -2.381 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.4 m -56.99 -24.82 56.3 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 113.432 -1.713 . . . . 0.0 112.471 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -80.46 -41.72 23.91 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -107.47 -20.18 13.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.99 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.31 12.18 73.79 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.457 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -113.74 168.3 9.89 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 122.392 -0.476 . . . . 0.0 110.953 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 25.0 p -97.19 133.91 41.2 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.451 0.643 . . . . 0.0 111.377 -177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -75.03 127.87 34.24 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.199 0.523 . . . . 0.0 110.74 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.82 143.02 31.14 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.866 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -101.14 134.44 44.15 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 73' ' ' TRP . 63.7 mt -73.16 122.5 26.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.283 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -95.29 -37.42 11.0 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.405 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -157.69 146.09 19.17 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.2 mt -118.5 130.42 73.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.157 0.503 . . . . 0.0 109.98 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -106.55 93.12 4.41 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.35 -19.74 65.89 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.884 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.25 -43.74 98.15 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.16 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -106.43 -10.87 16.13 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 73.98 30.93 60.54 Favored Glycine 0 N--CA 1.437 -1.268 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -175.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 31.0 p -113.85 156.04 24.64 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 122.576 -0.367 . . . . 0.0 110.608 -178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -132.69 145.03 50.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.936 0.398 . . . . 0.0 110.314 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 123.45 37.24 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.25 147.86 29.85 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -173.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 96.4 m -114.03 122.9 48.31 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -67.46 122.26 17.58 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.912 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.7 132.14 48.85 Favored 'General case' 0 C--N 1.316 -0.888 0 O-C-N 124.276 0.985 . . . . 0.0 110.763 -175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.22 4.09 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.906 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -66.95 -49.81 64.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.025 0.44 . . . . 0.0 110.466 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 97.21 20.1 24.07 Favored Glycine 0 N--CA 1.434 -1.451 0 N-CA-C 115.744 1.058 . . . . 0.0 115.744 176.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 107' ' ' THR . 88.3 m-20 -94.86 171.36 8.82 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 118.856 1.328 . . . . 0.0 109.591 176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.48 134.07 26.66 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.56 158.82 43.42 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 82.2 t -103.47 111.3 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -128.42 141.21 40.7 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.042 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.9 Cg_endo -60.03 149.38 84.76 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.653 2.236 . . . . 0.0 112.781 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 79.3 mt -58.56 -26.15 63.28 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 123.816 0.846 . . . . 0.0 111.394 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.5 pp -66.78 -32.35 73.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.324 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -81.56 -18.92 43.24 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.125 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 79' ' ' CYS . 74.1 mt -79.93 131.19 35.78 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.98 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 60.1 mttm -114.44 152.49 46.15 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -71.34 147.26 52.54 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.571 2.181 . . . . 0.0 110.306 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.417 HG21 ' HE3' ' A' ' 78' ' ' LYS . 27.6 m -84.44 126.0 40.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.04 145.73 50.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 174.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 72.45 -10.47 0.93 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.284 1.034 . . . . 0.0 112.414 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.081 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -178.496 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 100' ' ' GLU . . . . . . . . 0 CA--C 1.499 -0.996 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 m -79.3 -30.89 43.1 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.534 0.683 . . . . 0.0 109.37 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.5 m -103.38 131.42 50.47 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.714 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 64.3 tt0 -105.25 128.25 26.99 Favored Pre-proline 0 N--CA 1.416 -2.128 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 68' ' ' GLN . 37.7 Cg_exo -62.1 145.39 96.5 Favored 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.796 2.331 . . . . 0.0 111.476 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 37.8 m -73.77 -30.89 63.03 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.317 0.579 . . . . 0.0 109.994 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.465 ' HB3' ' NE1' ' A' ' 73' ' ' TRP . 32.4 m170 -83.83 122.68 29.02 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.59 0.709 . . . . 0.0 111.165 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -97.71 109.55 22.28 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.465 ' NE1' ' HB3' ' A' ' 71' ' ' HIS . 98.3 m95 -119.25 152.79 36.06 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.247 0.619 . . . . 0.0 111.738 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -127.08 159.31 34.56 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.963 0.411 . . . . 0.0 111.169 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.05 133.63 29.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.497 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.82 20.52 57.8 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.219 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.79 154.96 17.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -99.4 129.42 45.6 Favored 'General case' 0 N--CA 1.404 -2.773 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.446 ' SG ' HD22 ' A' ' 122' ' ' LEU . 24.3 p -137.49 168.92 18.69 Favored 'General case' 0 C--N 1.255 -3.51 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.661 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 87.2 mmm -106.1 128.6 54.0 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.84 150.98 38.92 Favored 'General case' 0 C--N 1.265 -3.072 0 O-C-N 123.865 0.728 . . . . 0.0 109.039 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -87.33 114.03 25.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -68.44 115.69 8.14 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.1 t -61.44 -16.93 51.67 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 124.068 0.855 . . . . 0.0 111.436 -175.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -84.6 -35.42 22.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -111.01 -19.85 12.62 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.894 -0.723 . . . . 0.0 112.303 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.79 8.74 86.39 Favored Glycine 0 C--N 1.312 -0.794 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.007 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -114.04 168.56 9.71 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.549 -0.383 . . . . 0.0 110.908 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 12.4 p -98.06 134.23 41.43 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.955 0.407 . . . . 0.0 112.018 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -136.75 157.22 47.26 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 124.505 1.122 . . . . 0.0 108.894 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.53 126.06 29.94 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-O 121.445 0.641 . . . . 0.0 111.211 -178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.44 153.05 42.25 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.936 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -107.95 137.33 46.14 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.1 mt -74.62 122.0 27.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.058 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.24 -32.59 13.61 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.781 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -165.28 150.9 9.48 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 mt -121.57 136.78 57.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -118.04 90.82 3.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.58 -17.11 64.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.891 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 10.7 tp10 -65.57 -42.84 91.34 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 109.343 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -98.02 -14.4 20.56 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.262 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.48 28.29 55.7 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 16.7 p -114.2 167.46 10.67 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 120.971 0.415 . . . . 0.0 111.381 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -142.51 144.24 32.89 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.68 121.02 33.68 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.6 pp -125.04 152.7 31.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.27 -172.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 99.6 m -123.46 122.89 39.39 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -67.38 123.09 19.4 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.817 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.16 136.9 52.83 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 124.312 1.007 . . . . 0.0 110.466 -175.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.49 -59.93 4.02 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.167 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -68.85 -49.74 55.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 120.879 0.371 . . . . 0.0 110.354 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 95.49 29.72 8.62 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.792 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 107' ' ' THR . 94.0 m-20 -104.03 163.25 12.5 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 117.811 0.806 . . . . 0.0 109.529 174.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 134.43 37.31 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 120.821 0.343 . . . . 0.0 110.334 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.82 159.69 42.09 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.83 114.18 41.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.3 t -127.95 141.6 41.7 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -175.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.6 Cg_endo -59.73 147.66 91.23 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.4 2.067 . . . . 0.0 111.889 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 75.5 mt -57.45 -26.62 61.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.01 -28.75 70.01 Favored 'General case' 0 C--O 1.213 -0.826 0 C-N-CA 123.481 0.712 . . . . 0.0 109.988 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -86.63 -7.43 58.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.678 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.1 mt -92.07 131.26 37.48 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.194 0.521 . . . . 0.0 110.888 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 58.2 mttm -115.38 156.09 46.23 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -74.97 139.77 24.74 Favored 'Trans proline' 0 C--O 1.247 0.966 0 C-N-CA 122.009 1.806 . . . . 0.0 110.344 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG12 ' SD ' ' A' ' 80' ' ' MET . 27.8 m -75.26 156.73 6.06 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.49 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -88.5 141.87 28.18 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -94.77 138.99 31.87 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.05 0.452 . . . . 0.0 111.378 -175.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.268 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.803 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.226 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m 68.28 -66.03 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.383 1.473 . . . . 0.0 113.379 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.1 m -78.77 105.34 10.01 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -95.08 118.97 66.45 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.92 150.24 43.48 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.789 2.326 . . . . 0.0 111.924 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.4 t -93.55 0.3 56.58 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.298 0.57 . . . . 0.0 110.668 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -115.0 128.83 56.51 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 55.7 m -91.53 126.58 36.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' HB3' HD13 ' A' ' 94' ' ' ILE . 94.8 m95 -121.33 151.77 39.72 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.729 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -131.86 160.75 34.77 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 123.763 0.665 . . . . 0.0 109.446 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.72 128.19 25.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.23 19.78 44.68 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.45 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -100.67 155.25 17.99 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HB3' HG11 ' A' ' 125' ' ' VAL . 67.1 mmtt -93.94 129.99 40.2 Favored 'General case' 0 N--CA 1.406 -2.632 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 122' ' ' LEU . 25.0 p -140.08 174.18 10.78 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 49.3 mtp -117.92 130.53 56.28 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.11 152.96 34.58 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -176.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.4 t -89.1 114.09 26.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -68.03 116.15 8.34 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 t -61.67 -17.07 53.98 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.781 0.676 . . . . 0.0 111.867 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -83.2 -41.69 18.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -109.3 -18.75 13.51 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.083 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.19 16.96 73.02 Favored Glycine 0 C--N 1.316 -0.547 0 C-N-CA 121.293 -0.48 . . . . 0.0 113.394 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -114.47 169.04 9.34 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 122.463 -0.433 . . . . 0.0 110.847 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 16.0 p -99.83 134.41 42.77 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.201 0.524 . . . . 0.0 111.402 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -138.24 157.54 46.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.262 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -74.12 130.45 39.8 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.476 0.655 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.03 146.75 37.63 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.345 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -107.02 137.31 45.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' A' ' 73' ' ' TRP . 62.6 mt -75.92 122.78 30.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.905 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -94.56 -35.51 12.22 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.8 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.4 149.28 18.77 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.03 124.35 70.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.97 96.24 7.41 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.75 -23.37 66.72 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.925 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.69 -42.37 77.88 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.511 0.672 . . . . 0.0 110.688 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -96.21 -14.44 22.71 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.966 0.412 . . . . 0.0 110.301 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.41 32.93 57.27 Favored Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 12.6 p -113.86 157.97 21.65 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-O 121.227 0.537 . . . . 0.0 111.834 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -133.43 138.31 46.16 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 110.208 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.64 120.97 31.39 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.5 pp -125.02 149.69 29.71 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.797 -172.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.8 m -118.11 126.81 52.99 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -72.37 116.8 13.25 Favored 'General case' 0 CA--C 1.496 -1.096 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.912 -178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 124.89 25.38 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.548 -1.206 . . . . 0.0 111.671 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.39 -41.59 2.16 Favored Glycine 0 N--CA 1.435 -1.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -86.01 -48.76 8.37 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 120.591 0.234 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 100.54 24.88 9.04 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.398 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.39 167.31 10.25 Favored 'General case' 0 CA--C 1.485 -1.549 0 CA-C-N 118.539 1.169 . . . . 0.0 109.508 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -144.99 133.01 21.34 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 106' ' ' ILE . 6.9 pt-20 -143.1 159.74 41.71 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -100.42 113.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.7 t -130.23 140.96 40.25 Favored Pre-proline 0 C--N 1.287 -2.151 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 25.7 Cg_endo -59.87 147.9 90.71 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.626 2.217 . . . . 0.0 112.47 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.0 -26.95 61.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.808 0.843 . . . . 0.0 111.155 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.1 pp -63.64 -32.93 74.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.128 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 63.2 m-20 -79.86 -16.14 55.99 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.176 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.464 HD22 ' SG ' ' A' ' 79' ' ' CYS . 80.9 mt -83.36 131.97 35.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.304 0.574 . . . . 0.0 111.802 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 86.2 mttt -114.65 159.11 38.41 Favored Pre-proline 0 C--N 1.307 -1.269 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.641 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -73.04 149.24 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.754 1.636 . . . . 0.0 109.606 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 78' ' ' LYS . 34.5 m -76.39 143.99 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.491 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -83.36 150.21 26.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.633 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.05 0.37 51.47 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.519 0.676 . . . . 0.0 110.683 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.409 -3.116 0 N-CA-C 108.496 -1.841 . . . . 0.0 108.496 179.402 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1129 ' ' 2MR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_